<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2022.1092837</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The protective role of nutritional antioxidants against oxidative stress in thyroid disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Macvanin</surname>
<given-names>Mirjana T.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/174475"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gluvic</surname>
<given-names>Zoran</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/953422"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zafirovic</surname>
<given-names>Sonja</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/815268"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/329785"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Essack</surname>
<given-names>Magbubah</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/183085"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Isenovic</surname>
<given-names>Esma R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/887392"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Radiobiology and Molecular Genetics, VIN&#x10c;A Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade</institution>, <addr-line>Belgrade</addr-line>, <country>Serbia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Clinic for Internal Medicine, Department of Endocrinology and Diabetes, Zemun Clinical Hospital, School of Medicine, University of Belgrade</institution>, <addr-line>Belgrade</addr-line>, <country>Serbia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST)</institution>, <addr-line>Thuwal</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Computer Science Program, Computer, Electrical and Mathematical Sciences and Engineering Division (CEMSE), King Abdullah University of Science and Technology (KAUST)</institution>, <addr-line>Thuwal</addr-line>, <country>Saudi Arabia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Luna Samanta, Ravenshaw University, India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jelena Djordjevic, Faculty of Biology, University of Belgrade, Serbia; Aleksandra Klisic, Primary Health Care Center Podgorica, Montenegro; Mohamed A. Haidara, Cairo University, Egypt</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Mirjana T. Macvanin, <email xlink:href="mailto:mirjana.macvanin@vin.bg.ac.rs">mirjana.macvanin@vin.bg.ac.rs</email>; Esma R. Isenovic, <email xlink:href="mailto:isenovic@yahoo.com">isenovic@yahoo.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1092837</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Macvanin, Gluvic, Zafirovic, Gao, Essack and Isenovic</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Macvanin, Gluvic, Zafirovic, Gao, Essack and Isenovic</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>An imbalance between pro-oxidative and antioxidative cellular mechanisms is oxidative stress (OxS) which may be systemic or organ-specific. Although OxS is a consequence of normal body and organ physiology, severely impaired oxidative homeostasis results in DNA hydroxylation, protein denaturation, lipid peroxidation, and apoptosis, ultimately compromising cells&#x2019; function and viability. The thyroid gland is an organ that exhibits both oxidative and antioxidative processes. In terms of OxS severity, the thyroid gland&#x2019;s response could be physiological (i.e. hormone production and secretion) or pathological (i.e. development of diseases, such as goitre, thyroid cancer, or thyroiditis). Protective nutritional antioxidants may benefit defensive antioxidative systems in resolving pro-oxidative dominance and redox imbalance, preventing or delaying chronic thyroid diseases. This review provides information on nutritional antioxidants and their protective roles against impaired redox homeostasis in various thyroid pathologies. We also review novel findings related to the connection between the thyroid gland and gut microbiome and analyze the effects of probiotics with antioxidant properties on thyroid diseases.</p>
</abstract>
<kwd-group>
<kwd>oxidative stress</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>thyroid disease</kwd>
<kwd>nutritional antioxidants</kwd>
<kwd>thyroid-gut axis</kwd>
<kwd>gut microbiome</kwd>
<kwd>antioxidant probiotic</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="246"/>
<page-count count="19"/>
<word-count count="7976"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Cellular redox homeostasis depends on a dynamic equilibrium between prooxidant production and its elimination. Reactive oxygen species (ROS), together with reactive nitrogen species (RNS), represent the most important prooxidants whose excessive accumulation leads to oxidative stress (OxS) and molecular damage (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). ROS are molecules with an oxygen atom, and unpaired electrons are primarily generated as by-products of ATP synthesis in mitochondrial respiratory chains (<xref ref-type="bibr" rid="B1">1</xref>) or during inflammation (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). The concentration of ROS determines their physiological role (<xref ref-type="bibr" rid="B5">5</xref>). When present at low concentrations, ROS are involved in signaling processes essential for normal cellular functions (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>), whereas high ROS concentration leads to DNA, lipid, and protein damage and apoptosis (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>ROS are crucial in thyroid function because they are essential in the initial stages of thyroid hormone synthesis during iodide oxidation (<xref ref-type="bibr" rid="B9">9</xref>). Also, the process whereby thyroid peroxidase (TPO) catalyzes thyroxine (T4) and triiodothyronine (T3) during its synthesis in thyroid follicles involves ROS (<xref ref-type="bibr" rid="B10">10</xref>). In addition, thyroid hormones affect the mitochondrial activity and modulate ROS production (<xref ref-type="bibr" rid="B10">10</xref>). The dependence of normal thyroid function on ROS implies that the thyroid is continuously exposed to ROS and, thus, particularly sensitive to oxidative damage (<xref ref-type="bibr" rid="B10">10</xref>). Therefore, to protect the integrity of the thyroid, it is mandatory that the thyroid antioxidant defence system effectively regulates and balances ROS production and elimination (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Aerobic organisms have evolved multiple antioxidant and repair systems for protection against OxS. Enzymes that decompose ROS, such as catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GR) provide the primary antioxidant defence (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B13">13</xref>). In contrast, ROS-induced damage repair systems eliminate damaged cells through autophagy and apoptosis processes (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). However, the capacity of intrinsic antioxidant systems is not always sufficient to prevent damage caused by excessive accumulation of ROS. Thus, non-enzymatic mechanisms based on the action of molecules with antioxidant properties such as glutathione (GSH), thioredoxin, coenzyme Q10, and exogenous antioxidants, including various polyphenolic compounds, ascorbic acid, tocopherol retinol, and &#x3b2;-carotene, that may also support antioxidant systems are essential. The use of nutritional antioxidants as supplementary substances that delay and/or prevent the oxidation of cellular components has shown the potential to protect human organs, including the thyroid gland, against oxidative damage by reinforcing the body&#x2019;s antioxidant defence and increasing total antioxidant capacity (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>Recently, a search for natural nutritional antioxidants from biological resources has gained substantial attention. Of particular interest are probiotics which represent live non-pathogenic microorganisms that can restore microbial balance in the gastrointestinal tract upon appropriate administration (<xref ref-type="bibr" rid="B18">18</xref>). Evidence demonstrates that probiotic bacteria exert significant antioxidant effects <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>), and the connection between the thyroid gland and gut microbiome is well-established. Furthermore, it has been documented that dysbiosis, an imbalance in gut microbiota, is associated with impaired thyroid function and pathogenesis of thyroid disorders such as Hashimoto&#x2019;s and Graves&#x2019; disease (<xref ref-type="bibr" rid="B23">23</xref>). In this review, we discuss the protective role of exogenous nutritional antioxidants in the context of various thyroid disorders. We also review novel findings related to the connection between the thyroid gland and gut microbiome and analyze the effects of probiotics with antioxidant properties on thyroid diseases.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Search strategy</title>
<p>We searched MEDLINE and PubMed for all English and non-English articles with English abstracts published between 1977 and 2022. The leading search terms were: oxidative stress, reactive oxygen species, thyroid disease, nutritional antioxidants, thyroid-gut axis, gut microbiome, and antioxidant probiotics. The search retrieved original peer-reviewed research articles, which were further analyzed, focusing on the role of nutritional antioxidants in thyroid diseases. We specifically focused on including the most recent findings published in the past five years.</p>
</sec>
<sec id="s3">
<label>3</label>
<title>Oxidative stress</title>
<p>Oxidative stress is a disbalance caused by excessive production of prooxidant substances such as ROS and RNS and/or the antioxidant systems working inefficiently (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). ROS include superoxide anion, hydroxyl radical, and hydrogen peroxide, which are produced <italic>in vivo</italic> primarily by the mitochondrial respiratory chain during aerobic metabolism (<xref ref-type="bibr" rid="B26">26</xref>). RNS family includes peroxynitrite, generated <italic>via</italic> a reaction between nitric oxide (NO) and superoxide, and nitrosoperoxycarbonate, generated <italic>via</italic> a reaction between peroxynitrite and carbon dioxide. Under physiological conditions, ROS plays a vital role in maintaining cellular homeostasis by regulating the endogenous antioxidant pool (<xref ref-type="bibr" rid="B27">27</xref>&#x2013;<xref ref-type="bibr" rid="B30">30</xref>) and participating in host defence and hormone synthesis (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>). In thyrocytes, ROS production is essential for their functional role (<xref ref-type="bibr" rid="B33">33</xref>) since TPO-mediated hormone synthesis depends on the action of dual oxidases (DUOX), enzymes responsible for H<sub>2</sub>O<sub>2</sub> production (<xref ref-type="bibr" rid="B34">34</xref>). However, when ROS and RNS are present in excessive amounts and/or in the form of highly reactive free radicals such as superoxide anion and hydroxyl radical, they oxidize susceptible biomolecules such as membrane lipids, cellular proteins, and nucleic acids, leading to disruption of normal cellular functions (<xref ref-type="bibr" rid="B35">35</xref>). Lipid peroxidation is a process in which oxidants such as free radicals or non-radical species attack lipids containing carbon-carbon double bond(s), especially polyunsaturated fatty acids (PUFAs) (<xref ref-type="bibr" rid="B36">36</xref>). The main lipid peroxidation products are hydroperoxides, such as propanal, hexanal, 4-hydroxynonenal, and malondialdehyde (MDA) (<xref ref-type="bibr" rid="B37">37</xref>). Phospholipids, cholesterol, and glycolipids are also targets of potentially lethal peroxidative modifications (<xref ref-type="bibr" rid="B38">38</xref>). ROS can also cause damage to DNA by oxidizing nucleoside bases (<xref ref-type="bibr" rid="B39">39</xref>). For example, guanine oxidation produces 8-oxo guanine (8-oxoG), which may lead to G-T or G-A transversions if unrepaired. The guanine and deoxyguanosine oxidation products 8-oxoG and its nucleotide 8-oxo-2&#x2032;-deoxyguanosine (8-oxodG) are ROS-mediated DNA lesions considered the most significant biomarkers for oxidative DNA damage (<xref ref-type="bibr" rid="B40">40</xref>). Oxidized bases are usually recognized and repaired by the base excision pathway (BER). Still, when they co-occur on opposing strands, BER can lead to the generation of double-stranded DNA breaks (<xref ref-type="bibr" rid="B41">41</xref>). ROS accumulation also induces mitochondrial DNA lesions, strand breaks, and DNA degradation (<xref ref-type="bibr" rid="B42">42</xref>). In addition, increased ROS levels are responsible for protein oxidation that can rapidly contribute to the augmentation of OxS by directly affecting cell structure, cell signaling, and essential enzymatic metabolic processes. Several modes of ROS-mediated protein oxidation are reported, including metal-catalyzed oxidation, oxidation-induced cleavage, amino acid oxidation, and the conjugation of lipid peroxidation products (<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>Excessive ROS accumulation is an important factor in the pathogenesis of different diseases. For instance, an elevated ROS production by the respiratory chain is observed in obesity as a response to metabolic overload caused by excess macronutrients and increased substrate availability (<xref ref-type="bibr" rid="B44">44</xref>). Mitochondrial dysfunction and endothelial reticulum stress contribute to metabolic perturbances in the adipose tissue of obese patients (<xref ref-type="bibr" rid="B45">45</xref>). Consequent ROS accumulation leads to cell damage and pathogenesis of inflammatory and cardiovascular diseases (<xref ref-type="bibr" rid="B46">46</xref>). Furthermore, mitochondrial ROS acts as signaling molecules mediating pro-inflammatory cytokines&#x2019; production, further reinforcing the connection between OxS and inflammation (<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>Several enzymatic and non-enzymatic defence mechanisms that guard cells against free radical damage have been identified in different cellular localizations, including mitochondria, plasma membrane, endoplasmic reticulum, peroxisomes, and cytosol. For example, enzymes SOD, Cat, and GPx, and transition-metal binding proteins, such as transferrin, ferritin, and ceruloplasmin, inactivate free radicals (<xref ref-type="bibr" rid="B48">48</xref>). Three forms of SOD are known in mammals: cytoplasmic SOD (SOD1), mitochondrial SOD (SOD2), and extracellular SOD (SOD3) (<xref ref-type="bibr" rid="B49">49</xref>). SOD belongs to a group of metalloenzymes that catalyzes the dismutation of superoxide anion to hydrogen peroxide and molecular oxygen, while Cat decomposes hydrogen peroxide to water and molecular oxygen (<xref ref-type="bibr" rid="B50">50</xref>). In high H<sub>2</sub>O<sub>2</sub> levels, GPx also participates in detoxification by converting lipid peroxides to the corresponding alcohols. Hydrosoluble molecules with free radical scavenging properties such as ascorbic acid, albumin, bilirubin, urates and thiols, liposoluble coenzyme Q10, and vitamin E interfere with the lipid peroxidation by neutralizing the free radicals. In particular, liposoluble scavengers in cellular membranes have high diffusion rates, enabling them to abolish the radical chain reactions by immediately converting them into more stable and less reactive molecules (<xref ref-type="bibr" rid="B46">46</xref>). Additional defence mechanisms that reconstruct damaged molecules involve using specific phospholipase that removes peroxidized fatty acids, allowing the reacylation of damaged molecules (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>).</p>
</sec>
<sec id="s4">
<label>4</label>
<title>General overview of thyroid diseases</title>
<p>Thyroid hormones have a considerable impact on the cellular oxidative stress processes which is ascribed to their role in cellular metabolism and oxygen consumption (<xref ref-type="bibr" rid="B53">53</xref>). Thyroid hormones are produced by thyroid gland, released into circulation, and transported to all organs and cells where they exert their effect. An important role in production of thyroid hormones has hypothalamic-pituitary-thyroid axis. Hypothalamus production of thyrotropin-releasing hormone (TRH) stimulates anterior pituitary gland to secrete thyroid-stimulating hormone (TSH), which affects thyroid gland and leads to production of thyroid hormones. Thyroid gland mainly produces T4, a prohormone which needs to convert to T3 to become biologically active. T4 comprises about 80% of secreted thyroid hormones, while the other 20% is T3. Increased plasma values of thyroid hormones in circulation activate negative feedback loop and inhibit release of TSH (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>).</p>
<p>Thyroid hormones exhibit profound metabolic effects characterized by an increased rate of both catabolic and anabolic reactions, resulting in an overall acceleration of the basal metabolism which is associated with increased oxygen consumption, respiratory rate, energy expenditure, and heat production (<xref ref-type="bibr" rid="B56">56</xref>). In addition, altered thyroid hormones levels may cause changes in the number and activity of mitochondrial respiratory chain components which represent the principal cellular site of ROS production, ultimately leading to changes in the cellular redox environment and increased ROS generation (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). For instance, it has been reported that hypothyroidism-induced dysfunction of the mitochondrial respiratory chain is associated with increased production of free radicals (<xref ref-type="bibr" rid="B59">59</xref>) Thus, excess TSH in hypothyroidism may modulate oxidative stress processes (<xref ref-type="bibr" rid="B60">60</xref>) by augmenting the accumulation of ROS that result from both increased generation of free radicals and diminished capacity of the antioxidative defense systems.</p>
<p>Hypothyroidism is associated with an increased risk of atherosclerosis due to its metabolic effects (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>). It is commonly accompanied by hyperlipidemia which results from a disbalance between the rates of fatty acids&#x2019; synthesis and degradation and is characterized by elevated total cholesterol and low-density lipoprotein-cholesterol (LDL-C), thus providing the substrate for ROS-mediated lipid peroxidation (<xref ref-type="bibr" rid="B63">63</xref>&#x2013;<xref ref-type="bibr" rid="B66">66</xref>). Interestingly, products of lipid peroxidation may further increase overall cellular oxidative stress by facilitating the generation of free radicals through the formation of adducts with proteins, which increases direct free radical-induced protein oxidation (<xref ref-type="bibr" rid="B67">67</xref>).</p>
<p>In thyroid diseases, metabolic disorders associated with low-grade inflammation can also lead to an increased oxidative stress (<xref ref-type="bibr" rid="B68">68</xref>). For instance, chronic low-grade inflammation observed in Hashimoto&#x2019;s thyroiditis causes endothelial dysfunction which represents an early step in the development of atherosclerosis. Endothelial dysfunction is characterized by the reduction of bioavailability of NO, resulting in impaired endothelium-dependent vasodilation (<xref ref-type="bibr" rid="B69">69</xref>) and increased oxidative stress (<xref ref-type="bibr" rid="B70">70</xref>). However, it should be mentioned that there is still no consensus in the literature regarding the connection between hypothyroidism and oxidative stress. Some studies report increased oxidative stress in hypothyroidism while other suggest that hypometabolic state that is prevalent in hypothyroidism may protects tissues from oxidative damage.</p>
<p>Thyroid diseases are considered the most commonly reported endocrine diseases in clinical practice, followed by lipid and carbohydrate disorders (<xref ref-type="bibr" rid="B71">71</xref>&#x2013;<xref ref-type="bibr" rid="B73">73</xref>). The primary thyroid condition that affects thyroid functionality presents as hyperthyroidism or hypothyroidism (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>.). Thyroid dysfunction could manifest fully (clinically) or latently (subclinically). Based on duration, thyroid dysfunction could be persistent or transitional (<xref ref-type="bibr" rid="B73">73</xref>&#x2013;<xref ref-type="bibr" rid="B75">75</xref>). The natural history of thyroid disorders can negatively affect the morphology and function of target tissues if left untreated or improperly treated (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B76">76</xref>). Thus, the leading causes of death in patients with thyroid dysfunctions are the consequences of atherosclerosis acceleration and the worsening of pre-existing cardiovascular and central nervous system diseases (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>). Such endpoints depend on pronounced OxS and diminished antioxidant defense systems at the molecular level (<xref ref-type="bibr" rid="B79">79</xref>&#x2013;<xref ref-type="bibr" rid="B81">81</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Thyroid gland&#x2019;s response to oxidative stress in: <bold>(A)</bold> physiological and <bold>(B)</bold> pathological conditions. <uri xlink:href="http://Biorender.com">Biorender.com</uri> was used to generate part of the Figure.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1092837-g001.tif"/>
</fig>
</sec>
<sec id="s5">
<label>5</label>
<title>Thyroid diseases and OxS</title>
<p>Different thyroidopathies have been shown to cause increased ROS production and evident OxS-induced damage to thyroid cells. This relationship is reciprocal since thyroid conditions can worsen OxS and increase ROS production, exacerbating oxidative damage. Thyroid hormones increase ROS release in the mitochondrial respiratory chain (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>). Hypothyroidism contributes to OxS through an inefficient antioxidant defence system, opposite to hyperthyroidism, where increased ROS production promotes OxS and oxidative damage of thyroid cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>) (<xref ref-type="bibr" rid="B46">46</xref>). According to published research, preventive dietary antioxidant therapy may partially correct the redox imbalance, making it a viable method for preventing the onset of many chronic thyroidopathies (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<sec id="s5_1">
<label>5.1</label>
<title>Thyroid dysfunctions and OxS</title>
<sec id="s5_1_1">
<label>5.1.1</label>
<title>Hypothyroidism</title>
<p>Even in its subclinical form, hypothyroidism reduces antioxidant system activity, which promotes OxS, causing oxidative damage and altered lipid metabolism in thyroid cells (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B84">84</xref>). MDA, a by-product of ROS-induced lipid peroxidation, has also been found in higher serum concentrations in hypothyroid patients (<xref ref-type="bibr" rid="B79">79</xref>). Even though levothyroxine considerably reduces lipid peroxidation, the serum MDA levels never reach the levels seen in healthy individuals (<xref ref-type="bibr" rid="B85">85</xref>). In addition, accumulated oxygen free radicals in thyroid cells may inhibit TPO function and interfere with the synthesis and secretion of thyroid hormones, causing hypothyroidism (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B86">86</xref>).</p>
</sec>
<sec id="s5_1_2">
<label>5.1.2</label>
<title>Hyperthyroidism</title>
<p>ROS generation is increased by hyperthyroidism (<xref ref-type="bibr" rid="B87">87</xref>). The increased intracellular ATP consumption, increased tissue oxygen consumption and oxidative phosphorylation, overexpression of adrenergic receptors, and a decrease in antioxidant defensive mechanisms are the mechanisms of free radicals overproduction that favour OxS in hyperthyroid patients (<xref ref-type="bibr" rid="B46">46</xref>). In addition, patients with hyperthyroidism have increased rates of lipid peroxidation compared to euthyroid people, which is a sign of oxidative damage to membrane lipids (<xref ref-type="bibr" rid="B82">82</xref>). The link between hyperthyroidism and deteriorating OxS is suggested by the positive association between thyroid hormones and MDA, TSH, and GSH (<xref ref-type="bibr" rid="B83">83</xref>).</p>
</sec>
</sec>
<sec id="s5_2">
<label>5.2</label>
<title>Thyroid disorders and OxS</title>
<sec id="s5_2_1">
<label>5.2.1</label>
<title>Nodular goitre</title>
<p>OxS promotes thyroid cell proliferation (<xref ref-type="bibr" rid="B88">88</xref>, <xref ref-type="bibr" rid="B89">89</xref>). Elevated MDA levels were observed in tissues collected from patients with toxic and non-toxic multinodular goitre, accompanied by reduced activity of SOD, GPx, and selenium content compared to adjacent, healthy thyroid tissue. Tissues of benign thyroid nodules show significantly reduced total antioxidant status (TAS) and reduced oxidative stress index (OSI) (<xref ref-type="bibr" rid="B90">90</xref>). The presence of elevated OxS parameters in toxic multinodular goitre and decreased plasma GPx and GR activities were also demonstrated (<xref ref-type="bibr" rid="B91">91</xref>). These findings suggest an impaired redox balance and antioxidant defence in patients with toxic thyroid nodules and nodular goitre.</p>
<p>Additionally, rare loss-of-function germline mutations of Kelch-like ECH-associated protein 1 (KEAP1) could be detected in nodular goitre leading to Nrf2 pathway activation that favours transcription of cytoprotective and antioxidant enzymes (<xref ref-type="bibr" rid="B92">92</xref>). The thyroid nodule size may change in both directions over time. The decrease in the size of thyroid nodules may result from supplementation with extracts of plants with antioxidant and anti-inflammatory properties (<xref ref-type="bibr" rid="B93">93</xref>).</p>
</sec>
<sec id="s5_2_2">
<label>5.2.2</label>
<title>Autoimmune thyroid diseases</title>
<sec id="s5_2_2_1">
<label>5.2.2.1</label>
<title>Hashimoto thyroiditis</title>
<p>By interacting with TPO and thyroglobulin (TG) and promoting immunogenicity by altering their morphology and function, NADPH-oxidases (NOXs) involvement in the production of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) regarding thyroid hormone synthesis may be related to the pathophysiology of AITD (<xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B95">95</xref>). More specifically, it has been demonstrated that an increase in ROS encourages the cleavage of TG into smaller fragments, which exposes the immune system to novel epitopes and intensifies the autoimmune response (<xref ref-type="bibr" rid="B96">96</xref>). OxS indicators are significantly higher when Hashimoto thyroiditis is associated with thyroid dysfunction. According to certain studies, the markers of worsened OxS in patients with Hashimoto thyroiditis were closely related to the levels of TG or TPO antibodies (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B97">97</xref>&#x2013;<xref ref-type="bibr" rid="B99">99</xref>).</p>
<p>Because it increases ROS production and lowers antioxidant levels, excessive iodine consumption is considered an additional risk factor for developing AITD. In people with Hashimoto thyroiditis, anti-TPO antibodies depend on GSH levels and exhibit an inverse correlation (<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B100">100</xref>). Additionally, there is a favourable association between total oxidative status (TOS) and OSI and both antibodies (anti-TG and anti-TPO). Reduced GSH levels seem to be a decisive factor in OxS activation and the development of Hashimoto thyroiditis (<xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B102">102</xref>). Additionally, it has been demonstrated that elevated TOS and OSI parameters may precede the development of hypothyroidism in autoimmune thyroiditis and may serve as indicators of thyroid cell injury (<xref ref-type="bibr" rid="B101">101</xref>&#x2013;<xref ref-type="bibr" rid="B103">103</xref>). Areas with lower-selenium soil have been linked to increased Hashimoto thyroiditis in humans (<xref ref-type="bibr" rid="B104">104</xref>). Also, genetic interactions between minor alleles in the selenoprotein S gene (<italic>SELENOS</italic>) and the nuclear factor erythroid 2-related factor 2 gene (<italic>NFE2L2</italic>) increase chronic thyroiditis incidences (<xref ref-type="bibr" rid="B105">105</xref>).</p>
</sec>
<sec id="s5_2_2_2">
<label>5.2.2.2</label>
<title>Graves&#x2019; disease</title>
<p>The most typical cause of hyperthyroidism is Graves&#x2019; disease (GD). Its natural history appears to be heavily influenced by oxidative DNA damage. Untreated GD sufferers were shown to have much more DNA damage than patients with toxic nodular goitre and healthy people (<xref ref-type="bibr" rid="B106">106</xref>). The highest level of OxS markers was recorded in hyperthyroid GD patients, especially ones with relapsing disease (<xref ref-type="bibr" rid="B107">107</xref>, <xref ref-type="bibr" rid="B108">108</xref>). Although both thiamazole and propylthiouracil effectively restore ROS and the antioxidative defence systems, some authors evidenced propylthiouracil as more efficacious (<xref ref-type="bibr" rid="B109">109</xref>). The unique mechanism of how OxS leads to GD is disrupting self-tolerance. The thyroid-stimulating antibodies (TSAb) present in GD are engaged in oxidation processes. As the markers of OxS show a positive correlation with TSAb, it may indicate that these variables may be involved in the breakdown of redox balance (<xref ref-type="bibr" rid="B110">110</xref>). In patients with GD, activating the nuclear factor erythroid 2&#x2013;related factor 2 (Nrf2) pathway may help restore thyroid function (<xref ref-type="bibr" rid="B105">105</xref>).</p>
</sec>
</sec>
<sec id="s5_2_3">
<label>5.2.3</label>
<title>Thyroid cancer</title>
<p>Increased production of ROS has been shown to favour cancer development (<xref ref-type="bibr" rid="B111">111</xref>). However, ROS can also trigger cell senescence and death, acting as an anti-tumorigenic agent (<xref ref-type="bibr" rid="B112">112</xref>). Disturbed genomic integrity induces oxidative genetic damage, DNA oxidation, the activation of proto-oncogenes, and the inactivation tumour suppressor genes leading to proliferative effects and mutagenesis (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B114">114</xref>). According to Krohn et&#xa0;al., DNA damage, a precursor to tumorigenesis, is thought to be caused by OxS (<xref ref-type="bibr" rid="B115">115</xref>). Resultant oxidative DNA base lesions have the potential to mutate some genetic material, which would impair the integrity of the genome by preventing transcription and replication and by generating mutagenesis (<xref ref-type="bibr" rid="B116">116</xref>). The oxidized form of guanine, 8-oxo-2&#x2032;-deoxyguanosine (8-oxo-dG), is a valuable marker of oxidative DNA damage during carcinogenesis (<xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B117">117</xref>). When compared to matched normal thyroid tissue, both benign (human follicular adenomas, or FTAs) and malignant (follicular (FTC) and papillary thyroid carcinoma (PTC)) lesions were found to have elevated nuclear levels of 8-oxo-dG (<xref ref-type="bibr" rid="B118">118</xref>) which most likely reflects the detrimental effects of prolonged exposure to chronic OxS seen during thyroid cancer (<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B118">118</xref>).</p>
<p>According to an analysis of the redox balance, sera antioxidant levels were lower in thyroid cancer patients than in healthy controls, and OxS marker sera levels in thyroid cancer patients were significantly higher than in the control samples (<xref ref-type="bibr" rid="B119">119</xref>). In addition, high concentrations of MDA in blood were detected in thyroid cancer patients, which unequivocally indicated reduced blood antioxidative capacity (<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B121">121</xref>).</p>
<p>A disturbed balance between serum OxS and antioxidant defence system markers is typically encountered in thyroid cancer patients compared to healthy individuals (<xref ref-type="bibr" rid="B119">119</xref>, <xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B123">123</xref>). The ineffective defence mechanism cannot neutralize ROS overproduction in thyroid cancer cells, leading to OxS (<xref ref-type="bibr" rid="B122">122</xref>). A significant difference in GPx activity and MDA levels was seen between the thyroid cancer patients before and after thyroidectomy in a study examining the change in OxS markers. Although thyroidectomy dramatically improved the oxidative status in favour of antioxidants, lipid peroxidation levels remained much more significant than in healthy thyroid people (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B124">124</xref>). Also, PTC patients exhibit a worse oxidative profile than patients with autoimmune thyroid disease and higher oxidative process rates than healthy individuals (<xref ref-type="bibr" rid="B125">125</xref>). Moreover, thyroid cancer risk was observed to be higher in obese people, and female patients with type 2 diabetes mellitus (T2DM) are more likely to have the extra-glandular invasion of PTC than male T2DM patients (<xref ref-type="bibr" rid="B126">126</xref>, <xref ref-type="bibr" rid="B127">127</xref>).</p>
<p>In PTC and anaplastic thyroid carcinoma, somatic <italic>KEAP1</italic> and <italic>NFE2L2</italic> mutations activating the Nrf2 pathway were discovered (<xref ref-type="bibr" rid="B128">128</xref>, <xref ref-type="bibr" rid="B129">129</xref>). Although the significance of such pathway activation in thyroid tumours is still unclear, it may help cancer cells survive (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B130">130</xref>). In addition, tumour tissue exhibit a higher quantity of ROS, which was linked to the decreased expression of selenium antioxidant proteins in cancer cells compared to healthy cells (<xref ref-type="bibr" rid="B122">122</xref>). Furthermore, compared to normal thyroid tissue, antioxidant catalase expression was significantly reduced in human thyroid tumours (<xref ref-type="bibr" rid="B131">131</xref>). These results show oxidant/antioxidant system in thyroid cancer tissue is imbalanced (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B132">132</xref>).</p>
</sec>
</sec>
</sec>
<sec id="s6">
<label>6</label>
<title>Nutrition and OxS</title>
<p>Proper nutritional intake is mandatory for overall well-being and better human health. However, dietary habits have an impact on human health and can lead to the development of a variety of disorders and diseases. The most prevalent diet in the world is the Western-style diet, characterized by an increased intake of refined food with a high caloric index and an increased amount of sugars and salt, while the intake of vegetables, fruits, and fish is reduced (<xref ref-type="bibr" rid="B133">133</xref>). Negative consequences of nutritional habits associated with a Western-style diet may lead to inflammation and production of free radicals (<xref ref-type="bibr" rid="B134">134</xref>) through the secretion of numerous pro-inflammatory molecules such as interleukin (IL)- 6, IL-1b, IL-8, and C-reactive protein (CRP), leading to the development of autoimmune disorders either directly, due to inflammation or disturbed immune balance, or indirectly due to increased fat depositions and the development of obesity. Obesity has the most severe consequences since it is associated with systemic inflammation, hypertension, and hypercholesterolemia, which represent conditions that increase the risk of developing cardiovascular disease and T2DM.</p>
<p>It is believed that the state after taking a meal (postprandial state) is pro-inflammatory and pro-oxidative, and the type of food mainly consumed affects the occurrence of OxS. As mentioned earlier, the increased intake of proteins (processed, red meats), sugars, salt, saturated and trans fat, and refined carbohydrates, which are characteristic of the Western-style diet, leads to the development of many diseases, which have their basis in the occurrence of OxS (<xref ref-type="bibr" rid="B135">135</xref>). Furthermore, a diet based on an increased intake of carbohydrates and fats leads to increased production of free radicals, directly affecting mitochondrial metabolism. Also, animals fed a high-fat diet have been shown to have increased OxS and dysfunctional mitochondria (<xref ref-type="bibr" rid="B136">136</xref>).</p>
<p>To reduce the development of obesity, cancer, diabetes, and cardiovascular diseases, WHO recommended a diet that includes an increased intake of fruits, vegetables, nuts, fish, and unsaturated fatty acids. This type of diet is represented in certain coastal regions of the world and has received the popular name Mediterranean diet. The natural antioxidants, as a result of proper nutritional habits, provide indirect protection by decreasing the production of cytokines and reducing OxS (<xref ref-type="bibr" rid="B134">134</xref>).</p>
<p>Numerous exogenous antioxidant molecules (nutritional antioxidants) have been shown to play an important role in excessive ROS accumulation in organisms. Here we will discuss several nutritional antioxidants with a confirmed protective antioxidant role. For instance, monounsaturated fatty acids (MUFA) such as oleic acid that are present in high amounts in olive oil and certain nuts decrease ROS production and exert protection against OxS (<xref ref-type="bibr" rid="B137">137</xref>). In addition, oleic acid showed anti-inflammatory effects by decreasing obesity and cytokine production and reducing cardiovascular mortality (<xref ref-type="bibr" rid="B134">134</xref>). The anti-inflammatory actions of MUFAs are based on their ability to counteract the effects of long-chain saturated fatty acids on hepatocytes, which include reducing endoplasmic reticulum stress, restricting lipotoxicity induced by accumulation of saturated fatty acids, decreasing ROS production, and inhibiting nuclear factor-&#x3ba;B (NF-kB) transcription factors by binding peroxisome proliferator-activated receptor &#x3b3; (PPAR&#x3b3;) and G-protein coupled surface receptor 120 (GPR120) (<xref ref-type="bibr" rid="B138">138</xref>). <italic>In vitro</italic>, MUFA has shown the ability to induce the expression of the adiponectin gene <italic>via</italic> PPAR&#x3b3; activation, which would result in decreased production of pro-inflammatory molecules such as IL-6 and tumour necrosis factor (TNF)-alpha (<xref ref-type="bibr" rid="B139">139</xref>)</p>
<p>Polyunsaturated fatty acids, such as omega-3 fatty acids (n-3 PUFA), are mostly found in eggs, nuts, and fish, whereas omega-6 fatty acid (n-6 PUFA) is predominantly present in sunflower and other vegetable oils. The ratio of n-3 PUFA/n-6 PUFA is of the utmost importance since its disbalance may activate pro-inflammatory pathways (<xref ref-type="bibr" rid="B140">140</xref>) n-3 and n-6 PUFA exert opposite effects on the immune system, whereas n-3 PUFA have an anti-inflammatory effect while n-6 PUFA induces a pro-inflammatory action (<xref ref-type="bibr" rid="B141">141</xref>). The anti-inflammatory effects of n-3 PUFA are based on their ability to decrease endogenous concentrations of ROS and expression of NF-kB and promote activation of genes involved in antioxidant protection.</p>
<p>Resveratrol (3,4&#x2032;,5-trihydroxy-trans-stilbene) is a natural polyphenol nonflavonoid compound primarily found in grapes, red wine, berries, and peanuts. It has been shown that long-term treatment with reservatrol prolongs lifespan and reduces OxS (<xref ref-type="bibr" rid="B142">142</xref>). In addition, resveratrol was shown to possess cardiovascular protective capacity (<xref ref-type="bibr" rid="B143">143</xref>&#x2013;<xref ref-type="bibr" rid="B145">145</xref>) and exhibit antidiabetic, anti-inflammatory, and antioxidant effects (<xref ref-type="bibr" rid="B146">146</xref>&#x2013;<xref ref-type="bibr" rid="B150">150</xref>), as well as the ability to suppress the proliferation of a variety of tumour cells (<xref ref-type="bibr" rid="B151">151</xref>, <xref ref-type="bibr" rid="B152">152</xref>). Also, resveratrol positively affects obesity, reducing triglycerides and glucose levels. The anti-inflammatory effects resulting from using resveratrol can be seen in the reduction of increased levels of interleukin and TNF in obese mice (<xref ref-type="bibr" rid="B15">15</xref>). The antioxidant effects of resveratrol were confirmed in many studies. For example, resveratrol significantly inhibited ROS production by polymorphonuclear leukocytes treated with formyl methionyl leucyl phenylalanine (<xref ref-type="bibr" rid="B153">153</xref>) and reduced OxS markers like glycated albumin levels in serum and 8-hydroxyguanosine in urine in stroke-prone spontaneously hypersensitive rats (<xref ref-type="bibr" rid="B154">154</xref>). Due to its lipophilic nature, resveratrol can bind to lipoprotein particles, which seems crucial for its antioxidant effects (<xref ref-type="bibr" rid="B155">155</xref>). Resveratrol consumption increases plasma antioxidant levels and decreases lipid peroxidation (<xref ref-type="bibr" rid="B156">156</xref>). It also reduces intracellular ROS and prevents LDL oxidation in endothelial cells (<xref ref-type="bibr" rid="B157">157</xref>) by inhibiting lipoxygenases (<xref ref-type="bibr" rid="B158">158</xref>). The mechanism by which resveratrol prevents LDL oxidation is based on its ability to chelate copper and scavenge ROS (<xref ref-type="bibr" rid="B159">159</xref>).</p>
<p>Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is a natural polyphenol derived from the rhizomes of the herbs from genus <italic>Curcuma</italic>, particularly from <italic>Curcuma longa</italic> (turmeric), <italic>Curcuma amada, Curcuma zedoaria, Curcuma aromatic</italic> and <italic>Curcuma raktakanta</italic>. (<xref ref-type="bibr" rid="B160">160</xref>&#x2013;<xref ref-type="bibr" rid="B162">162</xref>). It has multiple positive effects on the organism, acting as an antioxidant and decreasing inflammation. Using macrophages, Lin et&#xa0;al. showed that curcumin treatment increased levels of SOD and Cat while decreasing levels of ROS (<xref ref-type="bibr" rid="B163">163</xref>). The anti-inflammatory effect of curcumin is most likely associated with its ability to inhibit cyclooxygenase-2 (COX-2), lipoxygenase (LOX), and inducible nitric oxide synthase (iNOS) (<xref ref-type="bibr" rid="B164">164</xref>). In addition, curcumin positively affects body weight and glucose, increases GPx activity (<xref ref-type="bibr" rid="B165">165</xref>), and decreases FFA, triglycerides, and cholesterol concentrations in diabetic rats (<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>Berberine (5,6-dihydro-9,10-dimethoxybenzo [g]-1,3-benzodioxolo [5,6-a] quinolizinium) is a plant alkaloid found and derived from numerous families of plants, such as <italic>Annonaceae, Menispermaceae, Papaveraceae, Ranunculaceae</italic>, etc. (<xref ref-type="bibr" rid="B166">166</xref>). Barberine has been shown to have numerous positive effects such as decreasing cholesterol levels and reducing weight and adipose tissue in obese mice. In addition, berberine decreases obesity- and diabetes-related inflammation (<xref ref-type="bibr" rid="B167">167</xref>). In the atherosclerotic mouse model, berberine activating the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway decreases OxS (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B168">168</xref>). Ma et&#xa0;al. (<xref ref-type="bibr" rid="B169">169</xref>) showed diabetic animal models administered berberine activates the Nrf2 pathway and decreases OxS.</p>
<p>It is important to mention micronutrients with antioxidant properties, such as vitamins. Since the body cannot synthesize sufficient amounts of vitamins, it is necessary to take them through food or supplements. Vitamin E acts as a regulator of cellular metabolism, and its deficiency leads to anaemia, dysregulation of energy metabolism, irregular mitochondrial function, and tissue damage resulting from increased lipid peroxidation (<xref ref-type="bibr" rid="B16">16</xref>). Vitamin D deficiency affects muscle function and leads to irregular cardiovascular function. Also, a lack of Vitamin D is connected with disrupted mitochondrial function and thus increased inflammation and OxS (<xref ref-type="bibr" rid="B16">16</xref>). However, it should be emphasized that an increased intake of vitamins has the opposite effect, increasing OxS. For example, it is well known that vitamin C has antioxidant properties; it reacts with ROS creating a product with poor reactivity that does not have detrimental effects. On the other hand, vitamin C may undergo the Fenton reaction, in which a highly reactive free radical is formed (<xref ref-type="bibr" rid="B170">170</xref>).</p>
</sec>
<sec id="s7">
<label>7</label>
<title>Nutritional antioxidants and thyroid disease</title>
<sec id="s7_1">
<label>7.1</label>
<title>Trace elements</title>
<sec id="s7_1_1">
<label>7.1.1</label>
<title>Iodine</title>
<p>An average adult body contains around 15 to 20 mg of iodine located predominantly in the thyroid gland, which performs an essential role in synthesizing thyroid hormones. In addition to being a component of the thyroid hormone, iodine can act as an antioxidant and antiproliferative agent (<xref ref-type="bibr" rid="B171">171</xref>). Its uptake is mediated by the sodium/iodide symporter (NIS), expressed in thyroid cells and extrathyroidal tissues, including the stomach and salivary glands. The iodine content in food is determined by its amount in the soil. Since seafood and seaweed are rich sources of iodine, a diet based on high seafood consumption is sufficient. Likewise, fortifying salt and milk products with iodine ensures an adequate amount of dietary iodine (<xref ref-type="bibr" rid="B172">172</xref>, <xref ref-type="bibr" rid="B173">173</xref>). Although iodine deficiency was associated with goitre and thyroid nodules, PTC appears to be more common in areas with high iodine intake, which points to the complex relationship between iodine intake and thyroid disease (<xref ref-type="bibr" rid="B174">174</xref>). For instance, excessive iodine intake is associated with a transient reduction of thyroid hormone synthesis for approximately 24 hours after ingestion, known as the Wolff-Chaikoff effect (<xref ref-type="bibr" rid="B175">175</xref>). In patients with autoimmune thyroid disease or on anti-thyroid drug therapy, increased iodine intake can induce hypothyroidism, whereas, in patients with diffuse nodular goitre or latent Grave&#x2019;s disease, it can cause hyperthyroidism (<xref ref-type="bibr" rid="B176">176</xref>).</p>
</sec>
<sec id="s7_1_2">
<label>7.1.2</label>
<title>Zinc</title>
<p>Zinc is regarded as an antioxidative trace element because it is a co-factor of the enzyme SOD, which scavenges free radicals. Zinc is essential for normal thyroid function since it is required for the activity of enzyme 1,5&#x2032;-deiodinase which catalyzes the conversion of T4 to T3. In addition, zinc plays a vital role in the thyroid hormones&#x2019; metabolism by regulating thyrotropin-releasing hormone (TRH) and TSH synthesis and modulating the structures of essential transcription factors involved in synthesizing thyroid hormones (<xref ref-type="bibr" rid="B177">177</xref>, <xref ref-type="bibr" rid="B178">178</xref>). Zinc deficiency affects the thyroid gland by impairing TRH, TSH, T3, and T4 synthesis. In animal studies, free levels of T3 and T4 were reduced by approximately 30% (<xref ref-type="bibr" rid="B179">179</xref>), and a similar trend was observed in studies of human subjects. Hypothyroid patients often present with reduced levels of zinc. In a study designed to evaluate zinc metabolism in patients with thyroid disease, plasma and erythrocyte zinc concentration and urinary zinc excretion were investigated in hypo- and hyperthyroid patients (<xref ref-type="bibr" rid="B180">180</xref>). The mean concentration of plasma zinc in hypothyroid patients was lower than that of healthy control subjects, whereas no statistically significant differences were observed in plasma zinc values between hyperthyroid patients and control subjects. However, erythrocyte zinc concentration was significantly decreased in hyperthyroid patients compared to hypothyroid patients and accompanied by an increased urinary zinc excretion resulting from increased muscle tissue catabolism in hyperthyroid patients. The findings of this study suggest that abnormal zinc metabolism commonly occurs in thyroid dysfunctions (<xref ref-type="bibr" rid="B180">180</xref>) (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>The role of nutritional antioxidants in thyroid function.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Nutritional antioxidant</th>
<th valign="top" align="center">Role in thyroid function</th>
<th valign="top" align="center">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Iodine</td>
<td valign="top" align="left">Essential for the synthesis of thyroid hormones<break/>Antioxidant<break/>Antiproliferative agent</td>
<td valign="top" align="left">
<xref ref-type="bibr" rid="B171">171</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Zinc</td>
<td valign="top" align="left">Required for the activity of enzyme 1,5&#x2032;-deiodinase which catalyzes the conversion of T4 to T3<break/>Regulator of TRH and TSH synthesis</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B177">177</xref>, <xref ref-type="bibr" rid="B178">178</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Selenium</td>
<td valign="top" align="left">Constituent of selenoproteins<break/>Cofactor of Gpx, deiodinases and thioredoxin reductases</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B181">181</xref>&#x2013;<xref ref-type="bibr" rid="B183">183</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Resveratrol</td>
<td valign="top" align="left">Mediates the levels of TSH and iodide uptake in thyrocytes by decreasing sodium/iodide symporter expression</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B184">184</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Berberine</td>
<td valign="top" align="left">Decreases the abundance of pathogenic bacteria in the gut<break/>Increases the content of beneficial bacteria in the gut</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B185">185</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Inositol</td>
<td valign="top" align="left">Regulates thyroid hormone synthesis by forming H<sub>2</sub>O<sub>2</sub> in thyrocytes<break/>Involved in TSH signaling pathway</td>    <td valign="top" align="left">(<xref ref-type="bibr" rid="B187">187</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">L-carnitine</td>
<td valign="top" align="left">inhibit thyroid hormone entry into the nucleus of hepatocytes, neurons, and fibroblasts</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B186">186</xref>, <xref ref-type="bibr" rid="B187">187</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Probiotics</td>
<td valign="top" align="left">
<italic>Lactobacilli</italic> and <italic>Bifidobacteriaceae</italic> supplementation increase levothyroxine availability<break/>Reduce thyroid hormone serum fluctuation<break/>Increase the availability of bacterial enzymes sulfatases and &#xdf;-glucuronidases that regulate iodothyronines deconjugation</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B188">188</xref>, <xref ref-type="bibr" rid="B189">189</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>TRH, thyrotropin-releasing hormone; TSH, thyroid stimulating hormone; GPx, glutathione peroxidase; H<sub>2</sub>O<sub>2,</sub> hydrogen peroxide.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s7_1_3">
<label>7.1.3</label>
<title>Selenium</title>
<p>Selenium is an essential trace mineral whose functions in the organism are mainly connected to its antioxidant properties (<xref ref-type="bibr" rid="B190">190</xref>). Selenium is essential to antioxidant enzymes such as GPx (<xref ref-type="bibr" rid="B183">183</xref>) and is involved in thyroid and immune system functions. The thyroid gland has the highest concentration of selenium in the body, which is predominantly stored in the thyrocytes in the form of selenoproteins, such as deiodinases, GPx, and thioredoxin reductases (<xref ref-type="bibr" rid="B181">181</xref>, <xref ref-type="bibr" rid="B182">182</xref>). Adequate selenium intake is mandatory for the normal function of thyrocytes, and selenium deficiency is associated with the decreased synthesis of thyroid hormones (<xref ref-type="bibr" rid="B191">191</xref>), increased thyroid volume, and increased number of thyroid nodules (<xref ref-type="bibr" rid="B182">182</xref>, <xref ref-type="bibr" rid="B192">192</xref>). Selenium has been shown to affect T-cell differentiation and modulate the T-helper (Th) cells&#x2019; responses. Th cells are cytokine-producing cells that are divided into subgroups 1 and 2 depending on their mechanisms of action; Th1 cells are involved in cell-mediated immunity, whereas Th2 cells participate in antibody-mediated immunity. Th1 cytokine production generally tends to exert pro-inflammatory effects and may lead to autoimmune conditions such as Hashimoto&#x2019;s thyroiditis. Th2-induced hyperproduction of the thyroid autoantibodies observed in In Graves&#x2019; disease results in hyperthyroidism. Selenium deficiency has been associated with Th2 cell response, whereas higher selenium levels favour Th1 response (<xref ref-type="bibr" rid="B193">193</xref>). These findings may explain the beneficial effects of selenium supplementation in autoimmune thyroid diseases (<xref ref-type="bibr" rid="B181">181</xref>, <xref ref-type="bibr" rid="B194">194</xref>), such as reduced levels of anti-thyroid antibodies, improved thyroid structure and metabolism, and ameliorated clinical symptoms (<xref ref-type="bibr" rid="B181">181</xref>, <xref ref-type="bibr" rid="B195">195</xref>). Dietary forms of selenium include selenomethionine present in plant products and inorganic selenium forms used for supplementation (<xref ref-type="bibr" rid="B196">196</xref>). No indication of an increased risk of thyroid cancer in either selenium deficiency or exogenous supplementation has been reported (<xref ref-type="bibr" rid="B182">182</xref>) (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s7_2">
<label>7.2</label>
<title>Natural polyphenols and alkaloids</title>
<p>As an antioxidant polyphenolic compound and a free radical scavenger, resveratrol has attracted interest for the potential treatment of thyroid diseases accompanied by increased ROS production, such as autoimmune thyroiditis and hyperthyroidism (<xref ref-type="bibr" rid="B197">197</xref>). In addition, resveratrol may help treat thyroid cancer since it can induce apoptosis of thyroid cancer cells by increasing the abundance and phosphorylation of p53 tumour suppressor protein (p53) (<xref ref-type="bibr" rid="B198">198</xref>, <xref ref-type="bibr" rid="B199">199</xref>). <italic>In vitro</italic> and <italic>in vivo</italic> studies have also demonstrated that resveratrol mediates the levels of TSH and iodide uptake in thyrocytes by decreasing NIS expression (<xref ref-type="bibr" rid="B184">184</xref>). However, the observed effects also resulted in significant proliferative action of thyrocytes; thus, resveratrol may be a thyroid-disrupting compound and a goitrogen (<xref ref-type="bibr" rid="B184">184</xref>). Currently, data from clinical studies on resveratrol&#x2019;s effect on the thyroid in humans are absent, and all literature evidence is based on studies performed in cell cultures and animal models. Therefore, proper randomized clinical trials are mandatory to reach the final verdict on the potential use of resveratrol in treating thyroid diseases.</p>
<p>Alkaloid antioxidant berberine was recently reported to exert positive effects in treating GD. When supplemented in combination with methimazole, berberine significantly altered the microbiota composition of patients, decreasing the abundance of the pathogenic bacteria <italic>Chryseobacterium indologenes</italic> and <italic>Enterobacter hormaechei</italic> while simultaneously increasing the content of the beneficial bacteria <italic>Lactococcus lactis (</italic>
<xref ref-type="bibr" rid="B185">185</xref>
<italic>)</italic>. In addition, berberine supplementation resulted in significantly elevated enterobactin production, improving iron functioning and restoring thyroid function in patients with Graves&#x2019; disease (<xref ref-type="bibr" rid="B185">185</xref>) (see <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
</sec>
<sec id="s7_3">
<label>7.3</label>
<title>Inositol</title>
<p>Inositol (also known as vitamin B8) is a carbohydrate compound that is an essential component of the plasma membrane phospholipids and has an important role in synthesizing secondary messengers in the cells (<xref ref-type="bibr" rid="B200">200</xref>). Inositol is involved in signaling hormones such as TSH, insulin, and gonadotropins. Myoinositol (Myo), a cyclic polyol with six hydroxyl groups, is the most abundant isoform of inositol, mainly derived from the dietary intake of fruits, beans, and nuts. In contrast, its endogenous production is generated either from glucose by enzymatic reactions or by <italic>de novo</italic> catabolism of phosphatidylinositol (PI), phosphoinositides (PIP), and inositol phosphates (IP). Myo has a crucial role in thyroid function and autoimmune diseases due to its regulation of thyroid hormone synthesis by forming H<sub>2</sub>O<sub>2</sub> in thyrocytes. Myo is involved in the TSH signaling pathway; thus, depleted levels of Myo may cause the pathogenesis of thyroid diseases such as hypothyroidism (<xref ref-type="bibr" rid="B187">187</xref>). It has been observed that TSH levels significantly decreased in patients with subclinical hypothyroidism, with or without autoimmune thyroiditis, after treatment with Myo in combination with selenium (<xref ref-type="bibr" rid="B201">201</xref>, <xref ref-type="bibr" rid="B202">202</xref>). Studies of patients with Hashimoto&#x2019;s thyroiditis and subclinical hypothyroidism showed that supplementation of Myo and selenomethionine significantly decreased TSH, TPOAb, and TGAb concentrations, while simultaneously increasing thyroid hormones levels and restoring euthyroid state in patients with autoimmune thyroiditis (<xref ref-type="bibr" rid="B203">203</xref>, <xref ref-type="bibr" rid="B204">204</xref>). In addition, the combined treatment with Myo and selenomethionine was found to have an ameliorating effect on nodular thyroid disease by promoting a significant reduction of thyroid nodules size and number and regression of their stiffness (<xref ref-type="bibr" rid="B205">205</xref>). Additional <italic>in vitro</italic> and <italic>in vivo</italic> studies are required to investigate the mechanism of this effect and the potential use of Myo, alone or in combination with selenomethionine, as a novel clinical treatment for the general management of autoimmune thyroiditis and thyroid nodules (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
</sec>
<sec id="s7_4">
<label>7.4</label>
<title>L-carnitine</title>
<p>L-Carnitine (3-Hydroxy-4-(trimethylazaniumyl) butanoate) is a biological compound that is ubiquitous in mammalian tissues and fluids where it is required for &#x3b2;-oxidation of fatty acids by facilitating their transport in the form of acyl-carnitine esters across the mitochondrial inner membrane (<xref ref-type="bibr" rid="B206">206</xref>). In addition, L-carnitine possesses significant antioxidant properties reflected in its ability to scavenge superoxide anion radical and hydrogen peroxide and chelate metal ions such as ferrous ions (<xref ref-type="bibr" rid="B207">207</xref>). <sc>L</sc>-carnitine was shown to positively impact cardiac function through reduced oxidative stress, inflammation, and necrosis of cardiac myocytes (<xref ref-type="bibr" rid="B208">208</xref>). As much as 75% of L-carnitine comes from the dietary intake of red meat and dairy products (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>), whereas only 25% is generated by endogenous biosynthesis. Muscles are the main reservoir of carnitine, storing 95% of the total amount of 120 mmol present in the adult human body (<xref ref-type="bibr" rid="B209">209</xref>)</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Classification of nutritional oxidants with protective roles against oxidative stress in thyroid diseases and their naturally occurring sources.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Nutritional antioxidant</th>
<th valign="top" align="center">Natural source</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="2" align="left">Vitamins</th>
</tr>
<tr>
<td valign="top" align="left">Vitamin E</td>
<td valign="top" align="left">Plant oils (wheat germ, sunflower, safflower, and soybean&#xa0;oil), nuts (almonds, peanuts), sunflower seeds, fruits, and vegetables</td>
</tr>
<tr>
<td valign="top" align="left">Vitamin D</td>
<td valign="top" align="left">Cod liver oil, salmon, swordfish, tuna fish, sardines, egg yolk, beef liver, dairy and plant milk fortified with vitamin D</td>
</tr>
<tr>
<td valign="top" align="left">Vitamin C</td>
<td valign="top" align="left">Citrus fruits (oranges, lemon, grapefruit), kiwi, strawberries, vegetables (bell peppers, tomatoes, broccoli,&#xa0;cabbage, cauliflower, white potatoes)</td>
</tr>
<tr>
<td valign="top" align="left">Inositol (vitamin B8)</td>
<td valign="top" align="left">Fruits (cantaloupe, citrus fruits), fibre-rich foods (beans, brown rice, sesame seeds, corn, wheat bran), nuts (almonds, peanuts)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Trace elements</th>
</tr>
<tr>
<td valign="top" align="left">Iodine</td>
<td valign="top" align="left">Seafood, seaweed, iodized table salt, dairy, eggs, chicken, beef liver</td>
</tr>
<tr>
<td valign="top" align="left">Zinc</td>
<td valign="top" align="left">Seafood, meat</td>
</tr>
<tr>
<td valign="top" align="left">Selenium</td>
<td valign="top" align="left">Brazil nuts, seafood, meat</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Monounsaturated fatty acids (MUFA)</th>
</tr>
<tr>
<td valign="top" align="left">Oleic acid</td>
<td valign="top" align="left">Olive and almond oil, nuts (hazelnuts, pecans, almonds)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Polyunsaturated fatty acids (PUFA)</th>
</tr>
<tr>
<td valign="top" align="left">Omega-3 fatty acids</td>
<td valign="top" align="left">Seafood, nuts and seeds (flaxseed, chia seeds, and walnuts), plant oils (flaxseed oil, soybean oil, and canola oil)</td>
</tr>
<tr>
<td valign="top" align="left">Omega-6 fatty acids</td>
<td valign="top" align="left">Vegetable oils (sunflower, corn, and grapeseed oil), nuts (walnuts, pine nuts)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Polyphenolic compounds</th>
</tr>
<tr>
<td valign="top" align="left">Resveratrol</td>
<td valign="top" align="left">Grapes, red wine, berries, peanuts</td>
</tr>
<tr>
<td valign="top" align="left">Curcumin</td>
<td valign="top" align="left">Rhizomes of the herbs from genus <italic>Curcuma</italic> (<italic>Curcuma longa</italic> (turmeric), <italic>Curcuma amada, Curcuma zedoaria, Curcuma aromatic</italic> and <italic>Curcuma raktakanta</italic>)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Alkaloids</th>
</tr>
<tr>
<td valign="top" align="left">Berberine</td>
<td valign="top" align="left">Plants (<italic>Annonaceae, Menispermaceae, Papaveraceae,&#xa0;Ranunculaceae</italic>)</td>
</tr>
<tr>
<th valign="top" colspan="2" align="left">Biological compounds</th>
</tr>
<tr>
<td valign="top" align="left">Carnitine</td>
<td valign="top" align="left">Red meat, dairy products</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The anti-thyroid effect of L-carnitine is based on its ability to inhibit thyroid hormone entry into the nucleus of hepatocytes, neurons, and fibroblasts (<xref ref-type="bibr" rid="B186">186</xref>, <xref ref-type="bibr" rid="B210">210</xref>). As a result, rather than being a direct inhibitor of thyroid gland function, it acts as a peripheral antagonist of thyroid hormone action (<xref ref-type="bibr" rid="B186">186</xref>). The first controlled clinical trial demonstrating the beneficial effects of L-carnitine in reducing elevated thyroid hormone circulating levels was conducted in 50 women receiving TSH-suppressive (L-T4) therapy for cytologically benign thyroid nodules (<xref ref-type="bibr" rid="B210">210</xref>). L-carnitine supplementation was shown to be effective in reversing and preventing symptoms of hyperthyroidism (<xref ref-type="bibr" rid="B210">210</xref>). Consequent studies showed that severe forms of GD-related hyperthyroidism, including thyroid storms, may be effectively treated with <sc>l</sc>-carnitine (<xref ref-type="bibr" rid="B211">211</xref>&#x2013;<xref ref-type="bibr" rid="B213">213</xref>), which may be partly explained by increased levels of thyroid hormones deplete the tissue deposits of <sc>l</sc>-carnitine (<xref ref-type="bibr" rid="B214">214</xref>). Interestingly, decreased concentration of L-carnitine was also found in the skeletal muscles of hypothyroid patients (<xref ref-type="bibr" rid="B215">215</xref>), suggesting that L-carnitine depletion in skeletal muscles may contribute to myopathy associated with either hypothyroidism or hyperthyroidism. A recent study demonstrated that L-carnitine supplementation might alleviate fatigue symptoms in hypothyroid patients (<xref ref-type="bibr" rid="B216">216</xref>). Further clinical studies are required to establish the usefulness of L-carnitine supplementation in hypothyroidism (see <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
</sec>
<sec id="s7_5">
<label>7.5</label>
<title>Probiotics</title>
<p>Probiotics are live non-pathogenic microorganisms with beneficial health effects for their hosts (<xref ref-type="bibr" rid="B217">217</xref>). Probiotics regulate the composition of the intestinal microbiota, stimulate humoral and cellular immunity; decrease the frequency and duration of diarrhoea; and eliminate harmful metabolites in the colon, such as ammonium and procancerogenic enzymes. In addition, certain probiotic strains possess antioxidant activity and may reduce damage caused by OxS (<xref ref-type="bibr" rid="B218">218</xref>). Probiotics improve metabolic diseases such as obesity and diabetes by modulating intestinal microbiota composition (<xref ref-type="bibr" rid="B219">219</xref>&#x2013;<xref ref-type="bibr" rid="B221">221</xref>). Furthermore, the oxidative stress in patients with T2DM can be ameliorated by multispecies probiotics (<xref ref-type="bibr" rid="B222">222</xref>).</p>
<p>Probiotic bacteria possess their antioxidant defence systems, such as enzymes SOD and Cat, and can chelate metal ions, such as ferrous and cupric ions, preventing them from catalyzing oxidation (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B223">223</xref>). In addition, probiotics can stimulate the host&#x2019;s antioxidant defence systems and increase the activity of antioxidant enzymes (<xref ref-type="bibr" rid="B224">224</xref>). For instance, intact cells and cell-free extracts of <italic>Bifidobacterium animalis</italic> 01 can scavenge hydroxyl radicals and superoxide anion <italic>in vitro</italic>, whereas <italic>in vivo</italic>, they increase the antioxidative enzyme activity (<xref ref-type="bibr" rid="B20">20</xref>). Lactic acid bacteria strains can defend against peroxide radicals, superoxide anions, and hydroxyl radicals (<xref ref-type="bibr" rid="B225">225</xref>, <xref ref-type="bibr" rid="B226">226</xref>). Human studies have shown elevated SOD and GPx activities, and improved total antioxidant status in T2DM patients supplemented with <italic>Lactobacillus acidophilus</italic> La5 and <italic>Bifidobacterium lactis</italic> Bb12 (<xref ref-type="bibr" rid="B227">227</xref>). <italic>Lactobacillus rhamnosus</italic> supplementation was shown to exert significant antioxidant protection in conditions of increased physical stress (<xref ref-type="bibr" rid="B228">228</xref>). In addition, probiotics produce various antioxidant metabolites, such as GSH and folate. <italic>Lactobacillus fermentum</italic> strains, E-3 and E-18, contain very high levels of GSH (<xref ref-type="bibr" rid="B226">226</xref>), which can, together with selenium-dependent GPx, eliminate hydroxyl radicals and peroxynitrite (<xref ref-type="bibr" rid="B229">229</xref>).</p>
<p>The enormous complexity of human microbiota is reflected in the finding that adult human organisms typically contain 10<sup>14</sup> bacteria in the gut, which is approximately ten times more bacterial cells than the number of human cells (<xref ref-type="bibr" rid="B230">230</xref>), with at least 400 different bacterial species (<xref ref-type="bibr" rid="B231">231</xref>). Most bacterial species in a healthy human microbiota belong to the genera <italic>Bacteroidetes</italic> and <italic>Firmicutes</italic> (<xref ref-type="bibr" rid="B232">232</xref>), whereas <italic>Actinobacteria</italic>, <italic>Proteobacteria</italic>, <italic>Fusobacteria</italic>, and <italic>Cyanobacteria</italic>, are less abundant (<xref ref-type="bibr" rid="B233">233</xref>). Furthermore, microbiota composition varies depending on its localization in the gastrointestinal system; therefore <italic>Bacilli</italic> class of the <italic>Firmicutes</italic> and <italic>Actinobacteria</italic> is enriched in the small intestine, whereas the <italic>Bacteroidetes</italic> family of the <italic>Firmicutes</italic> is predominantly present in the colon (<xref ref-type="bibr" rid="B234">234</xref>).</p>
<p>Gut microbiota in patients with thyroid diseases has a different composition compared to the healthy controls and typically contains a decreased content of <italic>Lactobacillaceae</italic> and <italic>Bifidobacteriaceae.</italic> (<xref ref-type="bibr" rid="B23">23</xref>). The family <italic>Lactobacillacae</italic> has important antioxidant properties and may exert protective effects on the thyroid. (<xref ref-type="bibr" rid="B235">235</xref>), and its decreased content may cause higher oxidative stress in the thyroid (<xref ref-type="bibr" rid="B23">23</xref>). In addition, opportunistic pathogens in gut microbiota were shown in patients suffering from thyroid disease (Zhang, <xref ref-type="bibr" rid="B235">235</xref>). Gut microbiota dysbiosis negatively affects the regulation of anti-inflammatory and immune system responses and appears to be associated with autoimmune diseases, inflammation, and some types of cancer (<xref ref-type="bibr" rid="B189">189</xref>, <xref ref-type="bibr" rid="B236">236</xref>, <xref ref-type="bibr" rid="B237">237</xref>). For instance, thyroid cancer is associated with the increased presence of <italic>Clostridiaceae</italic>, <italic>Neisseria</italic>, and <italic>Streptococcus</italic>, whereas in patients with thyroid nodules, a relative increase of <italic>Streptococcus</italic> and <italic>Neisseria</italic> compared to healthy controls was observed (<xref ref-type="bibr" rid="B235">235</xref>). Increased abundance of <italic>Neisseria</italic> has been linked to inflammatory disorders (<xref ref-type="bibr" rid="B238">238</xref>). In contrast, <italic>Clostridiaceae</italic> and <italic>Streptococcus</italic> were associated with carcinogenic effects and a higher risk of carcinomas (<xref ref-type="bibr" rid="B239">239</xref>, <xref ref-type="bibr" rid="B240">240</xref>), and those three seem to have a role in thyroid carcinogenesis (<xref ref-type="bibr" rid="B23">23</xref>).</p>
<p>Probiotic supplementation has substantial beneficial effects on thyroid hormones and thyroid function. It was demonstrated that <italic>Lactobacillus reuteri</italic> supplementation improves thyroid function in mice by increasing free T4 and thyroid mass (<xref ref-type="bibr" rid="B241">241</xref>). Microbiota modulation by probiotic supplementation of <italic>Lactobacilli</italic> and <italic>Bifidobacteriaceae</italic> increased levothyroxine availability in humans and stabilized thyroid function. Probiotics were shown to be beneficial in lowering serum hormone fluctuations (<xref ref-type="bibr" rid="B188">188</xref>), partly because iodothyronines deconjugation is regulated by bacterial enzymes sulfatases and &#xdf;-glucuronidases whose availability could be increased by probiotic supplementation (<xref ref-type="bibr" rid="B189">189</xref>). Finally, probiotics influence the uptake of minerals relevant to thyroid function, including selenium, iodine, iron, and zinc, and a synergistic effect of probiotics and trace elements on the total antioxidant capacity was observed <italic>in vivo</italic>. Although probiotic supplementation shows promising potential in improving thyroid function in thyroid diseases, further human studies on the effects of probiotics as adjuvant therapy for thyroid diseases are required (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s8" sec-type="conclusions">
<label>8</label>
<title>Conclusions</title>
<p>Besides the impairment of cellular redox homeostasis in thyroid gland cells, thyroid diseases significantly contribute to systemic redox imbalance. In that way, thyroid diseases are organ-confined and promote histological changes in distant organs by disturbing the vital cellular pathways. Therefore, the simultaneous treatment of thyroid diseases and substituting of nutraceutical antioxidants could beneficially affect different molecular mechanisms enabling the recovery of disturbed redox balance. Se levels are lower in people with thyroid dysfunctions, such as subclinical or overt hypothyroidism (<xref ref-type="bibr" rid="B242">242</xref>). In order to determine whether Se supplementation may impact the progression of autoimmune thyroid disease, some trials carried out in regions where the population has a diffusely low or borderline Se status inconsistently suggest that Se supplementation may cause a decrease in thyroid autoantibodies (<xref ref-type="bibr" rid="B243">243</xref>, <xref ref-type="bibr" rid="B244">244</xref>). The population heterogeneity, various Se formulations and the length of Se supplementation, as well as different thyroid function test and Se measurement strategies, are among the reasons for the study conclusions inconsistency (<xref ref-type="bibr" rid="B244">244</xref>). The benefit of Se supplementation could be expected in patients living in regions with low Se availability or who have low- or sub-optimal Se levels. The supplementation must be attentive as the reference ranges of Se blood levels are narrow, and the risk of insufficient or toxic supplementation is possible (<xref ref-type="bibr" rid="B245">245</xref>, <xref ref-type="bibr" rid="B246">246</xref>).</p>
<p>Accumulating evidence support the existence of a thyroid-gut axis and displays important correlations between the composition of the gut bacteria and thyroid function. Dysbiosis, a common finding in thyroid disorders, not only promotes local inflammation of the intestinal membrane but also directly affects thyroid hormone levels <italic>via</italic> its own deiodinase activity and TSH inhibition. In addition, gut microbiota can modulate the absorption of trace minerals, such as iodine, selenium, and zinc, that are essential for thyroid function, including iron. For instance, iodine deficiency may lead to goiter, whereas high iodine intake may induce thyroid dysfunction in susceptible patients. Supplementation with antioxidative probiotics has shown beneficial effects in thyroid diseases thus representing a potential adjuvant therapy for thyroid disorders. The advances in the field of microbiome research envision the future possibility of personalized treatment with probiotics that are specifically adjusted to individual patients. Nevertheless, more data from adequately powered human studies are required for further evaluation of the impact of gut microbiota on thyroid diseases and the potential for possible therapeutic interventions.</p>
</sec>
<sec id="s9" sec-type="author-contributions">
<title>Author contributions</title>
<p>MM wrote the article. ZG wrote the article. SZ wrote the article. ME wrote the article, XG wrote and critically reviewed the article and EI wrote and critically reviewed the article. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work is part of the collaboration between the Department of Radiobiology and Molecular Genetics, &#x201c;VIN&#x10c;A&#x201d; Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia, Clinic for Internal Medicine, Department of Endocrinology and Diabetes, Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade, Serbia, and KAUST. The research was funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Contract No#451-03-9/2021-14/200017) and King Abdullah University of Science and Technology (KAUST) through grant awards Nos. BAS/1/1624-01-01, FCC/1/1976-20-01, FCC/1/1976-26-01, and Contract No#OSR 4129.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The reviewer JD declared a shared affiliation with the authors MM, ZG, SZ, EI to the handling editor at the time of review.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakubczyk</surname> <given-names>K</given-names>
</name>
<name>
<surname>Dec</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ka&#x142;du&#x144;ska</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kawczuga</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kochman</surname> <given-names>J</given-names>
</name>
<name>
<surname>Janda</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Reactive oxygen species - sources, functions, oxidative damage</article-title>. <source>Pol Merkur Lekarski</source> (<year>2020</year>) <volume>48</volume>:<page-range>124&#x2013;7</page-range>.</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname> <given-names>H</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>DP</given-names>
</name>
</person-group>. <article-title>Reactive oxygen species (ROS) as pleiotropic physiological signalling agents</article-title>. <source>Nat Rev Mol Cell Biol</source> (<year>2020</year>) <volume>21</volume>:<page-range>363&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41580-020-0230-3</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shekhova</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Mitochondrial reactive oxygen species as major effectors of antimicrobial immunity</article-title>. <source>PloS Pathog</source> (<year>2020</year>) <volume>16</volume>:<elocation-id>e1008470</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1008470</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lian</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>ROS and diseases: role in metabolism and energy supply</article-title>. <source>Mol Cell Biochem</source> (<year>2020</year>) <volume>467</volume>:<fpage>1</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11010-019-03667-9</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Marzo</surname> <given-names>N</given-names>
</name>
<name>
<surname>Chisci</surname> <given-names>E</given-names>
</name>
<name>
<surname>Giovannoni</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The role of hydrogen peroxide in redox-dependent signaling: Homeostatic and pathological responses in mammalian cells</article-title>. <source>Cells</source> (<year>2018</year>) <volume>7</volume>:<page-range>156</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells7100156</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress</article-title>. <source>Redox Biol</source> (<year>2017</year>) <volume>11</volume>:<page-range>613&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.redox.2016.12.035</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname> <given-names>H</given-names>
</name>
<name>
<surname>Berndt</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>DP</given-names>
</name>
</person-group>. <article-title>Oxidative stress</article-title>. <source>Annu Rev Biochem</source> (<year>2017</year>) <volume>86</volume>:<page-range>715&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-045037</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schieber</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chandel</surname> <given-names>NS</given-names>
</name>
</person-group>. <article-title>ROS function in redox signaling and oxidative stress</article-title>. <source>Curr Biol</source> (<year>2014</year>) <volume>24</volume>:<page-range>R453&#x2013;462</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cub.2014.03.034</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massart</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hoste</surname> <given-names>C</given-names>
</name>
<name>
<surname>Virion</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ruf</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dumont</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Van Sande</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Cell biology of H2O2 generation in the thyroid: investigation of the control of dual oxidases (DUOX) activity in intact ex vivo thyroid tissue and cell lines</article-title>. <source>Mol Cell Endocrinol</source> (<year>2011</year>) <volume>343</volume>:<fpage>32</fpage>&#x2013;<lpage>44</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2011.05.047</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thanas</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ziros</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Chartoumpekis</surname> <given-names>DV</given-names>
</name>
</person-group>. <article-title>The Keap1/Nrf2 signaling pathway in the thyroid-2020 update</article-title>. <source>Antioxidants (Basel)</source> (<year>2020</year>) <volume>9</volume>:<lpage>1082</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox9111082</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poncin</surname> <given-names>S</given-names>
</name>
<name>
<surname>G&#xe9;rard</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Boucquey</surname> <given-names>M</given-names>
</name>
<name>
<surname>Senou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Calderon</surname> <given-names>PB</given-names>
</name>
<name>
<surname>Knoops</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content</article-title>. <source>Endocrinology</source> (<year>2008</year>) <volume>149</volume>:<page-range>424&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2007-0951</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ameziane El Hassani</surname> <given-names>R</given-names>
</name>
<name>
<surname>Buffet</surname> <given-names>C</given-names>
</name>
<name>
<surname>Leboulleux</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dupuy</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Oxidative stress in thyroid carcinomas: biological and clinical significance</article-title>. <source>Endocr Relat Cancer</source> (<year>2019</year>) <volume>26</volume>:<fpage>R131</fpage>&#x2013;<lpage>r143</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/erc-18-0476</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Oxidative stress: a concept in redox biology and medicine</article-title>. <source>Redox Biol</source> (<year>2015</year>) <volume>4</volume>:<page-range>180&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.redox.2015.01.002</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filomeni</surname> <given-names>G</given-names>
</name>
<name>
<surname>De Zio</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cecconi</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Oxidative stress and autophagy: the clash between damage and metabolic needs</article-title>. <source>Cell Death Differ</source> (<year>2015</year>) <volume>22</volume>:<page-range>377&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cdd.2014.150</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Biomarkers, oxidative stress and autophagy in skin aging</article-title>. <source>Ageing Res Rev</source> (<year>2020</year>) <volume>59</volume>:<elocation-id>101036</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.arr.2020.101036</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Margaritelis</surname> <given-names>NV</given-names>
</name>
<name>
<surname>Paschalis</surname> <given-names>V</given-names>
</name>
<name>
<surname>Theodorou</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Kyparos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nikolaidis</surname> <given-names>MG</given-names>
</name>
</person-group>. <article-title>Antioxidants in personalized nutrition and exercise</article-title>. <source>Adv Nutr</source> (<year>2018</year>) <volume>9</volume>:<page-range>813&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/advances/nmy052</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidative stress, nutritional antioxidants and beyond</article-title>. <source>Sci China Life Sci</source> (<year>2020</year>) <volume>63</volume>:<page-range>866&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11427-019-9591-5</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname> <given-names>NT</given-names>
</name>
</person-group>. <article-title>Probiotics</article-title>. <source>Am J Health Syst Pharm</source> (<year>2010</year>) <volume>67</volume>:<page-range>449&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2146/ajhp090168</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Yen</surname> <given-names>CL</given-names>
</name>
</person-group>. <article-title>Antioxidative ability of lactic acid bacteria</article-title>. <source>J Agric Food Chem</source> (<year>1999</year>) <volume>47</volume>:<page-range>1460&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/jf981149l</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> antioxidant activity of bifidobacterium animalis 01 isolated from centenarians</article-title>. <source>Curr Microbiol</source> (<year>2011</year>) <volume>62</volume>:<page-range>1097&#x2013;103</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00284-010-9827-7</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Persichetti</surname> <given-names>E</given-names>
</name>
<name>
<surname>De Michele</surname> <given-names>A</given-names>
</name>
<name>
<surname>Codini</surname> <given-names>M</given-names>
</name>
<name>
<surname>Traina</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Antioxidative capacity of lactobacillus fermentum LF31 evaluated <italic>in vitro</italic> by oxygen radical absorbance capacity assay</article-title>. <source>Nutrition</source> (<year>2014</year>) <volume>30</volume>:<page-range>936&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.nut.2013.12.009</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Bacillus amyloliquefaciens SC06 alleviates the oxidative stress of IPEC-1 <italic>via</italic> modulating Nrf2/Keap1 signaling pathway and decreasing ROS production</article-title>. <source>Appl Microbiol Biotechnol</source> (<year>2017</year>) <volume>101</volume>:<page-range>3015&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00253-016-8032-4</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knezevic</surname> <given-names>J</given-names>
</name>
<name>
<surname>Starchl</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tmava Berisha</surname> <given-names>A</given-names>
</name>
<name>
<surname>Amrein</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Thyroid-Gut-Axis: How does the microbiota influence thyroid function</article-title>? <source>Nutrients</source> (<year>2020</year>) <volume>12</volume>:<elocation-id>1769</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12061769</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrocco</surname> <given-names>I</given-names>
</name>
<name>
<surname>Altieri</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Measurement and clinical significance of biomarkers of oxidative stress in humans</article-title>. <source>Oxid Med Cell Longev</source> (<year>2017</year>) <volume>2017</volume>:<fpage>6501046</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/6501046</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kochman</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jakubczyk</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>The influence of oxidative stress on thyroid diseases</article-title>. <source>Antioxidants (Basel)</source> (<year>2021</year>) <volume>10</volume>:<elocation-id>1442</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox10091442</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hamasaki</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Mitochondrial oxidative stress and mitochondrial DNA</article-title>. <source>Clin Chem Lab Med</source> (<year>2003</year>) <volume>41</volume>:<page-range>1281&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1515/cclm.2003.195</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Bras</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cl&#xe9;ment</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Pervaiz</surname> <given-names>S</given-names>
</name>
<name>
<surname>Brenner</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Reactive oxygen species and the mitochondrial signaling pathway of cell death</article-title>. <source>Histol Histopathol</source> (<year>2005</year>) <volume>20</volume>:<page-range>205&#x2013;19</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14670/hh-20.205</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname> <given-names>M</given-names>
</name>
<name>
<surname>Leibfritz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Moncol</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cronin</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Mazur</surname> <given-names>M</given-names>
</name>
<name>
<surname>Telser</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title>. <source>Int J Biochem Cell Biol</source> (<year>2007</year>) <volume>39</volume>:<fpage>44</fpage>&#x2013;<lpage>84</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biocel.2006.07.001</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wink</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Hines</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>RY</given-names>
</name>
<name>
<surname>Switzer</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Flores-Santana</surname> <given-names>W</given-names>
</name>
<name>
<surname>Vitek</surname> <given-names>MP</given-names>
</name>
<etal/>
</person-group>. <article-title>Nitric oxide and redox mechanisms in the immune response</article-title>. <source>J Leukoc Biol</source> (<year>2011</year>) <volume>89</volume>:<page-range>873&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.1010550</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangge</surname> <given-names>H</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fuchs</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gostner</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Antioxidants, inflammation and cardiovascular disease</article-title>. <source>World J Cardiol</source> (<year>2014</year>) <volume>6</volume>:<page-range>462&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4330/wjc.v6.i6.462</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambeth</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>NOX enzymes and the biology of reactive oxygen</article-title>. <source>Nat Rev Immunol</source> (<year>2004</year>) <volume>4</volume>:<page-range>181&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri1312</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quinn</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Gauss</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases</article-title>. <source>J Leukoc Biol</source> (<year>2004</year>) <volume>76</volume>:<page-range>760&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1189/jlb.0404216</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cross</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>OT</given-names>
</name>
</person-group>. <article-title>Enzymic mechanisms of superoxide production</article-title>. <source>Biochim Biophys Acta</source> (<year>1991</year>) <volume>1057</volume>:<page-range>281&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0005-2728(05)80140-9</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohye</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sugawara</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Dual oxidase, hydrogen peroxide and thyroid diseases</article-title>. <source>Exp Biol Med (Maywood)</source> (<year>2010</year>) <volume>235</volume>:<page-range>424&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1258/ebm.2009.009241</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monaghan</surname> <given-names>P</given-names>
</name>
<name>
<surname>Metcalfe</surname> <given-names>NB</given-names>
</name>
<name>
<surname>Torres</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Oxidative stress as a mediator of life history trade-offs: mechanisms, measurements and interpretation</article-title>. <source>Ecol Lett</source> (<year>2009</year>) <volume>12</volume>:<fpage>75</fpage>&#x2013;<lpage>92</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1461-0248.2008.01258.x</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Porter</surname> <given-names>NA</given-names>
</name>
</person-group>. <article-title>Free radical lipid peroxidation: mechanisms and analysis</article-title>. <source>Chem Rev</source> (<year>2011</year>) <volume>111</volume>:<page-range>5944&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/cr200084z</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Umeno</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shichiri</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity <italic>in vivo</italic>
</article-title>. <source>J Clin Biochem Nutr</source> (<year>2013</year>) <volume>52</volume>:<fpage>9</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3164/jcbn.12-112</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayala</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mu&#xf1;oz</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Arg&#xfc;elles</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal</article-title>. <source>Oxid Med Cell Longev</source> (<year>2014</year>) <volume>2014</volume>:<elocation-id>360438</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2014/360438</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooke</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Dizdaroglu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lunec</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Oxidative DNA damage: mechanisms, mutation, and disease</article-title>. <source>FASEB J</source> (<year>2003</year>) <volume>17</volume>:<page-range>1195&#x2013;214</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.02-0752rev</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiorcea-Paquim</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>8-oxoguanine and 8-oxodeoxyguanosine biomarkers of oxidative DNA damage: A review on HPLC-ECD determination</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>:<elocation-id>1620</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27051620</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cannan</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Tsang</surname> <given-names>BP</given-names>
</name>
<name>
<surname>Wallace</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Pederson</surname> <given-names>DS</given-names>
</name>
</person-group>. <article-title>Nucleosomes suppress the formation of double-strand DNA breaks during attempted base excision repair of clustered oxidative damages</article-title>. <source>J Biol Chem</source> (<year>2014</year>) <volume>289</volume>:<page-range>19881&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M114.571588</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shokolenko</surname> <given-names>I</given-names>
</name>
<name>
<surname>Venediktova</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bochkareva</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Alexeyev</surname> <given-names>MF</given-names>
</name>
</person-group>. <article-title>Oxidative stress induces degradation of mitochondrial DNA</article-title>. <source>Nucleic Acids Res</source> (<year>2009</year>) <volume>37</volume>:<page-range>2539&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkp100</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cecarini</surname> <given-names>V</given-names>
</name>
<name>
<surname>Gee</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fioretti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Amici</surname> <given-names>M</given-names>
</name>
<name>
<surname>Angeletti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Eleuteri</surname> <given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>Protein oxidation and cellular homeostasis: Emphasis on metabolism</article-title>. <source>Biochim Biophys Acta</source> (<year>2007</year>) <volume>1773</volume>:<fpage>93</fpage>&#x2013;<lpage>104</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbamcr.2006.08.039</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turrens</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Boveris</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria</article-title>. <source>Biochem J</source> (<year>1980</year>) <volume>191</volume>:<page-range>421&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bj1910421</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmermann</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Aeberli</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review</article-title>. <source>Int J Obes (Lond)</source> (<year>2008</year>) <volume>32 Suppl 6</volume>:<page-range>S11&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ijo.2008.202</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mancini</surname> <given-names>A</given-names>
</name>
<name>
<surname>Di Segni</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Thyroid hormones, oxidative stress, and inflammation</article-title>. <source>Mediators Inflamm</source> (<year>2016</year>) <volume>2016</volume>:<fpage>6757154</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/6757154</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siti</surname> <given-names>HN</given-names>
</name>
<name>
<surname>Kamisah</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kamsiah</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)</article-title>. <source>Vascul Pharmacol</source> (<year>2015</year>) <volume>71</volume>:<fpage>40</fpage>&#x2013;<lpage>56</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vph.2015.03.005</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sakano</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ogino</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Kubo</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Relationship between ceruloplasmin and oxidative biomarkers including ferritin among healthy Japanese</article-title>. <source>J Clin Biochem Nutr</source> (<year>2013</year>) <volume>52</volume>:<page-range>160&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3164/jcbn.12-122</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>DH</given-names>
</name>
<etal/>
</person-group>. <article-title>Superoxide dismutase gene (SOD1, SOD2, and SOD3) polymorphisms and antituberculosis drug-induced hepatitis</article-title>. <source>Allergy Asthma Immunol Res</source> (<year>2015</year>) <volume>7</volume>:<fpage>88</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4168/aair.2015.7.1.88</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Baba</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation</article-title>. <source>Inflammation Res</source> (<year>2006</year>) <volume>55</volume>:<page-range>359&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00011-006-5195-y</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nigam</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schewe</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Phospholipase A(2)s and lipid peroxidation</article-title>. <source>Biochim Biophys Acta</source> (<year>2000</year>) <volume>1488</volume>:<page-range>167&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1388-1981(00)00119-0</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Six</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Dennis</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>The expanding superfamily of phospholipase A(2) enzymes: classification and characterization</article-title>. <source>Biochim Biophys Acta</source> (<year>2000</year>) <volume>1488</volume>:<fpage>1</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1388-1981(00)00105-0</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Messarah</surname> <given-names>M</given-names>
</name>
<name>
<surname>Saoudi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Boumendjel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Boulakoud</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Feki</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart</article-title>. <source>Environ Toxicol Pharmacol</source> (<year>2011</year>) <volume>31</volume>:<fpage>33</fpage>&#x2013;<lpage>41</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.etap.2010.09.003</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Spek</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Fliers</surname> <given-names>E</given-names>
</name>
<name>
<surname>Boelen</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Thyroid hormone metabolism in innate immune cells</article-title>. <source>J Endocrinol</source> (<year>2017</year>) <volume>232</volume>:<fpage>R67</fpage>&#x2013;<lpage>r81</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/joe-16-0462</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gluvic</surname> <given-names>ZM</given-names>
</name>
<name>
<surname>Zafirovic</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Obradovic</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Sudar-Milovanovic</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Rizzo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Isenovic</surname> <given-names>ER</given-names>
</name>
</person-group>. <article-title>Hypothyroidism and risk of cardiovascular disease</article-title>. <source>Curr Pharm Des</source> (<year>2022</year>) <volume>28</volume>:<page-range>2065&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1381612828666220620160516</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakrabarti</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Ghosh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chowdhury</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Oxidative stress in hypothyroid patients and the role of antioxidant supplementation</article-title>. <source>Indian J Endocrinol Metab</source> (<year>2016</year>) <volume>20</volume>:<page-range>674&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/2230-8210.190555</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venditti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Di Meo</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Thyroid hormone-induced oxidative stress</article-title>. <source>Cell Mol Life Sci</source> (<year>2006</year>) <volume>63</volume>:<page-range>414&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-005-5457-9</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sahoo</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Roy</surname> <given-names>A</given-names>
</name>
<name>
<surname>Samanta</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chainy</surname> <given-names>GB</given-names>
</name>
</person-group>. <article-title>Thiol redox status critically influences mitochondrial response to thyroid hormone-induced hepatic oxidative injury: A temporal analysis</article-title>. <source>Cell Biochem Funct</source> (<year>2010</year>) <volume>28</volume>:<page-range>126&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cbf.1631</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resch</surname> <given-names>U</given-names>
</name>
<name>
<surname>Helsel</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tatzber</surname> <given-names>F</given-names>
</name>
<name>
<surname>Sinzinger</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Antioxidant status in thyroid dysfunction</article-title>. <source>Clin Chem Lab Med</source> (<year>2002</year>) <volume>40</volume>:<page-range>1132&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1515/cclm.2002.198</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nanda</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bobby</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Hamide</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism</article-title>. <source>Clin Chem Lab Med</source> (<year>2008</year>) <volume>46</volume>:<page-range>674&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1515/cclm.2008.139</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hak</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Pols</surname> <given-names>HA</given-names>
</name>
<name>
<surname>Visser</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Drexhage</surname> <given-names>HA</given-names>
</name>
<name>
<surname>Hofman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Witteman</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study</article-title>. <source>Ann Intern Med</source> (<year>2000</year>) <volume>132</volume>:<page-range>270&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7326/0003-4819-132-4-200002150-00004</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gluvic</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sudar</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tica</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jovanovic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zafirovic</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tomasevic</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of levothyroxine replacement therapy on parameters of metabolic syndrome and atherosclerosis in hypothyroid patients: a prospective pilot study</article-title>. <source>Int J Endocrinol</source> (<year>2015</year>) <volume>2015</volume>:<elocation-id>147070</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2015/147070</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duntas</surname> <given-names>LH</given-names>
</name>
</person-group>. <article-title>Thyroid disease and lipids</article-title>. <source>Thyroid</source> (<year>2002</year>) <volume>12</volume>:<page-range>287&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/10507250252949405</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>V</given-names>
</name>
<name>
<surname>Tapia</surname> <given-names>G</given-names>
</name>
<name>
<surname>Varela</surname> <given-names>P</given-names>
</name>
<name>
<surname>Romanque</surname> <given-names>P</given-names>
</name>
<name>
<surname>Cartier-Ugarte</surname> <given-names>D</given-names>
</name>
<name>
<surname>Videla</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>Thyroid hormone-induced oxidative stress in rodents and humans: a comparative view and relation to redox regulation of gene expression</article-title>. <source>Comp Biochem Physiol C Toxicol Pharmacol</source> (<year>2006</year>) <volume>142</volume>:<page-range>231&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbpc.2005.10.007</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peppa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Betsi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Dimitriadis</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease</article-title>. <source>J Lipids</source> (<year>2011</year>) <volume>2011</volume>:<elocation-id>575840</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2011/575840</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizos</surname> <given-names>CV</given-names>
</name>
<name>
<surname>Elisaf</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Liberopoulos</surname> <given-names>EN</given-names>
</name>
</person-group>. <article-title>Effects of thyroid dysfunction on lipid profile</article-title>. <source>Open Cardiovasc Med J</source> (<year>2011</year>) <volume>5</volume>:<fpage>76</fpage>&#x2013;<lpage>84</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1874192401105010076</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negre-Salvayre</surname> <given-names>A</given-names>
</name>
<name>
<surname>Coatrieux</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ingueneau</surname> <given-names>C</given-names>
</name>
<name>
<surname>Salvayre</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Advanced lipid peroxidation end products in oxidative damage to proteins. potential role in diseases and therapeutic prospects for the inhibitors</article-title>. <source>Br J Pharmacol</source> (<year>2008</year>) <volume>153</volume>:<fpage>6</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.bjp.0707395</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gluvic</surname> <given-names>ZM</given-names>
</name>
<name>
<surname>Obradovic</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Sudar-Milovanovic</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Zafirovic</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Radak</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Essack</surname> <given-names>MM</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulation of nitric oxide production in hypothyroidism</article-title>. <source>BioMed Pharmacother</source> (<year>2020</year>) <volume>124</volume>:<elocation-id>109881</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2020.109881</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lerman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Burnett</surname> <given-names>JC</given-names>
<suffix>Jr</suffix>
</name>
</person-group>. <article-title>Intact and altered endothelium in regulation of vasomotion</article-title>. <source>Circulation</source> (<year>1992</year>) <volume>86</volume>:<page-range>III12&#x2013;19</page-range>.</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taddei</surname> <given-names>S</given-names>
</name>
<name>
<surname>Caraccio</surname> <given-names>N</given-names>
</name>
<name>
<surname>Virdis</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dardano</surname> <given-names>A</given-names>
</name>
<name>
<surname>Versari</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ghiadoni</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Low-grade systemic inflammation causes endothelial dysfunction in patients with hashimoto&#x2019;s thyroiditis</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2006</year>) <volume>91</volume>:<page-range>5076&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2006-1075</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canaris</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Manowitz</surname> <given-names>NR</given-names>
</name>
<name>
<surname>Mayor</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ridgway</surname> <given-names>EC</given-names>
</name>
</person-group>. <article-title>The Colorado thyroid disease prevalence study</article-title>. <source>Arch Intern Med</source> (<year>2000</year>) <volume>160</volume>:<page-range>526&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/archinte.160.4.526</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollowell</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Staehling</surname> <given-names>NW</given-names>
</name>
<name>
<surname>Flanders</surname> <given-names>WD</given-names>
</name>
<name>
<surname>Hannon</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Gunter</surname> <given-names>EW</given-names>
</name>
<name>
<surname>Spencer</surname> <given-names>CA</given-names>
</name>
<etal/>
</person-group>. <article-title>Serum TSH, T(4), and thyroid antibodies in the united states population, (1988 to 1994): National health and nutrition examination survey (NHANES III)</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2002</year>) <volume>87</volume>:<page-range>489&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jcem.87.2.8182</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berta</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lengyel</surname> <given-names>I</given-names>
</name>
<name>
<surname>Halmi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zr&#xed;nyi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Erdei</surname> <given-names>A</given-names>
</name>
<name>
<surname>Harangi</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Hypertension in thyroid disorders</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>482</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2019.00482</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Leo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Braverman</surname> <given-names>LE</given-names>
</name>
</person-group>. <article-title>Hyperthyroidism</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>388</volume>:<page-range>906&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(16)00278-6</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaker</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bianco</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Jonklaas</surname> <given-names>J</given-names>
</name>
<name>
<surname>Peeters</surname> <given-names>RP</given-names>
</name>
</person-group>. <article-title>Hypothyroidism</article-title>. <source>Lancet</source> (<year>2017</year>) <volume>390</volume>:<page-range>1550&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(17)30703-1</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delitala</surname> <given-names>AP</given-names>
</name>
</person-group>. <article-title>Subclinical hyperthyroidism and the cardiovascular disease</article-title>. <source>Horm Metab Res</source> (<year>2017</year>) <volume>49</volume>:<page-range>723&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0043-117893</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stamatouli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bedoya</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yavuz</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Hypothyroidism: Cardiovascular endpoints of thyroid hormone replacement</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>888</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2019.00888</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barreiro Arcos</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>Role of thyroid hormones-induced oxidative stress on cardiovascular physiology</article-title>. <source>Biochim Biophys Acta Gen Subj</source> (<year>2022</year>) <volume>1866</volume>:<elocation-id>130239</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbagen.2022.130239</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erdamar</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cimen</surname> <given-names>B</given-names>
</name>
<name>
<surname>G&#xfc;lcemal</surname> <given-names>H</given-names>
</name>
<name>
<surname>Saraymen</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yerer</surname> <given-names>B</given-names>
</name>
<name>
<surname>Demirci</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma</article-title>. <source>Clin Biochem</source> (<year>2010</year>) <volume>43</volume>:<page-range>650&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2010.02.005</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramli</surname> <given-names>NSF</given-names>
</name>
<name>
<surname>Mat Junit</surname> <given-names>S</given-names>
</name>
<name>
<surname>Leong</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Razali</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Analyses of antioxidant status and nucleotide alterations in genes encoding antioxidant enzymes in patients with benign and malignant thyroid disorders</article-title>. <source>PeerJ</source> (<year>2017</year>) <volume>5</volume>:. doi:&#xa0;<pub-id pub-id-type="doi">10.7717/peerj.3365</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuzan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kr&#xf3;lewicz</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Contribution of glycation and oxidative stress to thyroid gland pathology-a pilot study</article-title>. <source>Biomolecules</source> (<year>2021</year>) <volume>11</volume>:<elocation-id>557</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom11040557</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piazera</surname> <given-names>BKL</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>DV</given-names>
</name>
<name>
<surname>Vig&#xe1;rio</surname> <given-names>P</given-names>
</name>
<name>
<surname>Salerno</surname> <given-names>VP</given-names>
</name>
<name>
<surname>Vaisman</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Evaluation of redox profiles in exogenous subclinical hyperthyroidism at two different levels of TSH suppression</article-title>. <source>Arch Endocrinol Metab</source> (<year>2018</year>) <volume>62</volume>:<page-range>545&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.20945/2359-3997000000075</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahim</surname> <given-names>YA</given-names>
</name>
<name>
<surname>Sharaf</surname> <given-names>NE</given-names>
</name>
</person-group>. <article-title>Assessment of thyroid function and oxidative stress state in foundry workers exposed to lead</article-title>. <source>J Health Pollut</source> (<year>2020</year>) <volume>10</volume>:<fpage>200903</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5696/2156-9614-10.27.200903</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torun</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Kulaksizoglu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kulaksizoglu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pamuk</surname> <given-names>BO</given-names>
</name>
<name>
<surname>Isbilen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tutuncu</surname> <given-names>NB</given-names>
</name>
</person-group>. <article-title>Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism</article-title>. <source>Clin Endocrinol (Oxf)</source> (<year>2009</year>) <volume>70</volume>:<page-range>469&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2265.2008.03348.x</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baskol</surname> <given-names>G</given-names>
</name>
<name>
<surname>Atmaca</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tanriverdi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Baskol</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kocer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bayram</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment</article-title>. <source>Exp Clin Endocrinol Diabetes</source> (<year>2007</year>) <volume>115</volume>:<page-range>522&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-2007-981457</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fortunato</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Hecht</surname> <given-names>F</given-names>
</name>
<name>
<surname>Dupuy</surname> <given-names>C</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>DP</given-names>
</name>
</person-group>. <article-title>Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress</article-title>? <source>J Endocrinol</source> (<year>2014</year>) <volume>221</volume>:<page-range>R31&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/joe-13-0588</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcocci</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bartalena</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Role of oxidative stress and selenium in graves&#x2019; hyperthyroidism and orbitopathy</article-title>. <source>J Endocrinol Invest</source> (<year>2013</year>) <volume>36</volume>:<fpage>15</fpage>&#x2013;<lpage>20</lpage>.</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poncin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Van Eeckoudt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Humblet</surname> <given-names>K</given-names>
</name>
<name>
<surname>Colin</surname> <given-names>IM</given-names>
</name>
<name>
<surname>G&#xe9;rard</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Oxidative stress: a required condition for thyroid cell proliferation</article-title>. <source>Am J Pathol</source> (<year>2010</year>) <volume>176</volume>:<page-range>1355&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2353/ajpath.2010.090682</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruggeri</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Giovinazzo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Barbalace</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Cristani</surname> <given-names>M</given-names>
</name>
<name>
<surname>Alibrandi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vicchio</surname> <given-names>TM</given-names>
</name>
<etal/>
</person-group>. <article-title>Influence of dietary habits on oxidative stress markers in hashimoto&#x2019;s thyroiditis</article-title>. <source>Thyroid</source> (<year>2021</year>) <volume>31</volume>:<fpage>96</fpage>&#x2013;<lpage>105</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2020.0299</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faam</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ghadiri</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Ghaffari</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Totonchi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khorsandi</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Comparing oxidative stress status among Iranian males and females with malignant and non-malignant thyroid nodules</article-title>. <source>Int J Endocrinol Metab</source> (<year>2021</year>) <volume>19</volume>:<elocation-id>e105669</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.5812/ijem.105669</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bednarek</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wysocki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sowinski</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Oxidation products and antioxidant markers in plasma of patients with graves&#x2019; disease and toxic multinodular goiter: effect of methimazole treatment</article-title>. <source>Free Radic Res</source> (<year>2004</year>) <volume>38</volume>:<page-range>659&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10715760410001701621</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishihara</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hishinuma</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kogai</surname> <given-names>T</given-names>
</name>
<name>
<surname>Takada</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hirokawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fukata</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel germline mutation of KEAP1 (R483H) associated with a non-toxic multinodular goiter</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2016</year>) <volume>7</volume>:<elocation-id>131</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2016.00131</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stancioiu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mihai</surname> <given-names>D</given-names>
</name>
<name>
<surname>Papadakis</surname> <given-names>GZ</given-names>
</name>
<name>
<surname>Tsatsakis</surname> <given-names>A</given-names>
</name>
<name>
<surname>Spandidos</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Badiu</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Treatment for benign thyroid nodules with a combination of natural extracts</article-title>. <source>Mol Med Rep</source> (<year>2019</year>) <volume>20</volume>:<page-range>2332&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2019.10453</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duthoit</surname> <given-names>C</given-names>
</name>
<name>
<surname>Estienne</surname> <given-names>V</given-names>
</name>
<name>
<surname>Giraud</surname> <given-names>A</given-names>
</name>
<name>
<surname>Durand-Gorde</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Rasmussen</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Feldt-Rasmussen</surname> <given-names>U</given-names>
</name>
<etal/>
</person-group>. <article-title>Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity</article-title>? <source>Biochem J</source> (<year>2001</year>) <volume>360</volume>:<page-range>557&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/0264-6021:3600557</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gheorghiu</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Badiu</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Selenium involvement in mitochondrial function in thyroid disorders</article-title>. <source>Hormones (Athens)</source> (<year>2020</year>) <volume>19</volume>:<fpage>25</fpage>&#x2013;<lpage>30</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s42000-020-00173-2</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niethammer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Grabher</surname> <given-names>C</given-names>
</name>
<name>
<surname>Look</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Mitchison</surname> <given-names>TJ</given-names>
</name>
</person-group>. <article-title>A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish</article-title>. <source>Nature</source> (<year>2009</year>) <volume>459</volume>:<page-range>996&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature08119</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruggeri</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Vicchio</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Cristani</surname> <given-names>M</given-names>
</name>
<name>
<surname>Certo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Caccamo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Alibrandi</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidative stress and advanced glycation end products in hashimoto&#x2019;s thyroiditis</article-title>. <source>Thyroid</source> (<year>2016</year>) <volume>26</volume>:<page-range>504&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2015.0592</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Calderone</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bellanti</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Vitiligo and hashimoto&#x2019;s thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis</article-title>. <source>Med Hypotheses</source> (<year>2019</year>) <volume>128</volume>:<fpage>69</fpage>&#x2013;<lpage>75</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mehy.2019.05.010</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruggeri</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Campenn&#xcc;</surname> <given-names>A</given-names>
</name>
<name>
<surname>Giuffrida</surname> <given-names>G</given-names>
</name>
<name>
<surname>Casciaro</surname> <given-names>M</given-names>
</name>
<name>
<surname>Barbalace</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Hrelia</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidative stress as a key feature of autoimmune thyroiditis: an update</article-title>. <source>Minerva Endocrinol</source> (<year>2020</year>) <volume>45</volume>:<page-range>326&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.23736/s0391-1977.20.03268-x</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rostami</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nourooz-Zadeh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mohammadi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Khalkhali</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Ferns</surname> <given-names>G</given-names>
</name>
<name>
<surname>Nourooz-Zadeh</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Serum selenium status and its interrelationship with serum biomarkers of thyroid function and antioxidant defense in hashimoto&#x2019;s thyroiditis</article-title>. <source>Antioxidants (Basel)</source> (<year>2020</year>) <volume>9</volume>:<elocation-id>1070</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox9111070</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rostami</surname> <given-names>R</given-names>
</name>
<name>
<surname>Aghasi</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Mohammadi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nourooz-Zadeh</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Enhanced oxidative stress in hashimoto&#x2019;s thyroiditis: inter-relationships to biomarkers of thyroid function</article-title>. <source>Clin Biochem</source> (<year>2013</year>) <volume>46</volume>:<page-range>308&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2012.11.021</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ates</surname> <given-names>I</given-names>
</name>
<name>
<surname>Arikan</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Altay</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yilmaz</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Yilmaz</surname> <given-names>N</given-names>
</name>
<name>
<surname>Berker</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>The effect of oxidative stress on the progression of hashimoto&#x2019;s thyroiditis</article-title>. <source>Arch Physiol Biochem</source> (<year>2018</year>) <volume>124</volume>:<page-range>351&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13813455.2017.1408660</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baser</surname> <given-names>H</given-names>
</name>
<name>
<surname>Can</surname> <given-names>U</given-names>
</name>
<name>
<surname>Baser</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yerlikaya</surname> <given-names>FH</given-names>
</name>
<name>
<surname>Aslan</surname> <given-names>U</given-names>
</name>
<name>
<surname>Hidayetoglu</surname> <given-names>BT</given-names>
</name>
</person-group>. <article-title>Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis</article-title>. <source>Endocrine</source> (<year>2015</year>) <volume>48</volume>:<page-range>916&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12020-014-0399-3</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valea</surname> <given-names>A</given-names>
</name>
<name>
<surname>Georgescu</surname> <given-names>CE</given-names>
</name>
</person-group>. <article-title>Selenoproteins in human body: focus on thyroid pathophysiology</article-title>. <source>Hormones (Athens)</source> (<year>2018</year>) <volume>17</volume>:<page-range>183&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s42000-018-0033-5</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chartoumpekis</surname> <given-names>DV</given-names>
</name>
<name>
<surname>Ziros</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Habeos</surname> <given-names>IG</given-names>
</name>
<name>
<surname>Sykiotis</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>Emerging roles of Keap1/Nrf2 signaling in the thyroid gland and perspectives for bench-to-bedside translation</article-title>. <source>Free Radic Biol Med</source> (<year>2022</year>) <volume>190</volume>:<page-range>276&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2022.08.021</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarkovi&#x107;</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The role of oxidative stress on the pathogenesis of graves&#x2019; disease</article-title>. <source>J Thyroid Res</source> (<year>2012</year>) <volume>2012</volume>:<elocation-id>302537</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/302537</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ademo&#x11f;lu</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ozbey</surname> <given-names>N</given-names>
</name>
<name>
<surname>Erbil</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tanrikulu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Barbaros</surname> <given-names>U</given-names>
</name>
<name>
<surname>Yanik</surname> <given-names>BT</given-names>
</name>
<etal/>
</person-group>. <article-title>Determination of oxidative stress in thyroid tissue and plasma of patients with graves&#x2019; disease</article-title>. <source>Eur J Intern Med</source> (<year>2006</year>) <volume>17</volume>:<page-range>545&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejim.2006.04.013</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maouche</surname> <given-names>N</given-names>
</name>
<name>
<surname>Meskine</surname> <given-names>D</given-names>
</name>
<name>
<surname>Alamir</surname> <given-names>B</given-names>
</name>
<name>
<surname>Koceir</surname> <given-names>EA</given-names>
</name>
</person-group>. <article-title>Trace elements profile is associated with insulin resistance syndrome and oxidative damage in thyroid disorders: Manganese and selenium interest in Algerian participants with dysthyroidism</article-title>. <source>J Trace Elem Med Biol</source> (<year>2015</year>) <volume>32</volume>:<page-range>112&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtemb.2015.07.002</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kocak</surname> <given-names>M</given-names>
</name>
<name>
<surname>Akarsu</surname> <given-names>E</given-names>
</name>
<name>
<surname>Korkmaz</surname> <given-names>H</given-names>
</name>
<name>
<surname>Taysi</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>The effect of antithyroid drugs on osteopontin and oxidative stress in graves&#x2019; disease</article-title>. <source>Acta Endocrinol (Buchar)</source> (<year>2019</year>) <volume>15</volume>:<page-range>221&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4183/aeb.2019.221</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diana</surname> <given-names>T</given-names>
</name>
<name>
<surname>Daiber</surname> <given-names>A</given-names>
</name>
<name>
<surname>Oelze</surname> <given-names>M</given-names>
</name>
<name>
<surname>Neumann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Olivo</surname> <given-names>PD</given-names>
</name>
<name>
<surname>Kanitz</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Stimulatory TSH-receptor antibodies and oxidative stress in graves disease</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2018</year>) <volume>103</volume>:<page-range>3668&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2018-00509</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rhodes</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Moncol</surname> <given-names>J</given-names>
</name>
<name>
<surname>Izakovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mazur</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Free radicals, metals and antioxidants in oxidative stress-induced cancer</article-title>. <source>Chem Biol Interact</source> (<year>2006</year>) <volume>160</volume>:<fpage>1</fpage>&#x2013;<lpage>40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbi.2005.12.009</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collery</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Strategies for the development of selenium-based anticancer drugs</article-title>. <source>J Trace Elem Med Biol</source> (<year>2018</year>) <volume>50</volume>:<fpage>498</fpage>&#x2013;<lpage>507</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtemb.2018.02.024</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stone</surname> <given-names>JR</given-names>
</name>
</person-group>. <article-title>An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems</article-title>. <source>Arch Biochem Biophys</source> (<year>2004</year>) <volume>422</volume>:<page-range>119&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.abb.2003.12.029</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakashima</surname> <given-names>M</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Meirmanov</surname> <given-names>S</given-names>
</name>
<name>
<surname>Naruke</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Matsuu-Matsuyama</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shichijo</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis</article-title>. <source>Int J Cancer</source> (<year>2008</year>) <volume>122</volume>:<page-range>1082&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ijc.23223</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krohn</surname> <given-names>K</given-names>
</name>
<name>
<surname>Maier</surname> <given-names>J</given-names>
</name>
<name>
<surname>Paschke</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors</article-title>. <source>Nat Clin Pract Endocrinol Metab</source> (<year>2007</year>) <volume>3</volume>:<page-range>713&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncpendmet0621</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sedelnikova</surname> <given-names>OA</given-names>
</name>
<name>
<surname>Redon</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Dickey</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Georgakilas</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Bonner</surname> <given-names>WM</given-names>
</name>
</person-group>. <article-title>Role of oxidatively induced DNA lesions in human pathogenesis</article-title>. <source>Mutat Res</source> (<year>2010</year>) <volume>704</volume>:<page-range>152&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrrev.2009.12.005</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Analysis of a form of oxidative DNA damage, 8-hydroxy-2&#x2019;-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis</article-title>. <source>Mutat Res</source> (<year>1997</year>) <volume>387</volume>:<page-range>147&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1383-5742(97)00035-5</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karger</surname> <given-names>S</given-names>
</name>
<name>
<surname>Krause</surname> <given-names>K</given-names>
</name>
<name>
<surname>Engelhardt</surname> <given-names>C</given-names>
</name>
<name>
<surname>Weidinger</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gimm</surname> <given-names>O</given-names>
</name>
<name>
<surname>Dralle</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours</article-title>. <source>J Mol Endocrinol</source> (<year>2012</year>) <volume>48</volume>:<fpage>193</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/jme-11-0119</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>YW</given-names>
</name>
</person-group>. <article-title>Total oxidant/antioxidant status in sera of patients with thyroid cancers</article-title>. <source>Endocr Relat Cancer</source> (<year>2011</year>) <volume>18</volume>:<page-range>773&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/erc-11-0230</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geri&#x107;</surname> <given-names>M</given-names>
</name>
<name>
<surname>Domijan</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Glu&#x161;&#x10d;i&#x107;</surname> <given-names>V</given-names>
</name>
<name>
<surname>Janu&#x161;i&#x107;</surname> <given-names>R</given-names>
</name>
<name>
<surname>&#x160;ar&#x10d;evi&#x107;</surname> <given-names>B</given-names>
</name>
<name>
<surname>Garaj-Vrhovac</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Cytogenetic status and oxidative stress parameters in patients with thyroid diseases</article-title>. <source>Mutat Res Genet Toxicol Environ Mutagen</source> (<year>2016</year>) <volume>810</volume>:<page-range>22&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrgentox.2016.09.010</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heydarzadeh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kia</surname> <given-names>SK</given-names>
</name>
</person-group>. <article-title>The cross-talk between polyphenols and the target enzymes related to oxidative stress-induced thyroid cancer</article-title>. <source>Oxid Med Cell Longev</source> (<year>2022</year>) <volume>2022</volume>:<fpage>2724324</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/2724324</pub-id>
</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metere</surname> <given-names>A</given-names>
</name>
<name>
<surname>Frezzotti</surname> <given-names>F</given-names>
</name>
<name>
<surname>Graves</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Vergine</surname> <given-names>M</given-names>
</name>
<name>
<surname>De Luca</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pietraforte</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery</article-title>. <source>Cancer Cell Int</source> (<year>2018</year>) <volume>18</volume>:<fpage>7</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12935-018-0504-4</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rovcanin</surname> <given-names>B</given-names>
</name>
<name>
<surname>Stojsavljevic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kekic</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gopcevic</surname> <given-names>K</given-names>
</name>
<name>
<surname>Manojlovic</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jovanovic</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Redox status and antioxidative cofactor metals influence clinical and pathological characteristics of papillary thyroid carcinoma and colloid goiter</article-title>. <source>Biol Trace Elem Res</source> (<year>2020</year>) <volume>197</volume>:<page-range>349&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12011-019-01995-x</pub-id>
</citation>
</ref>
<ref id="B124">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akinci</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kosova</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cetin</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sepici</surname> <given-names>A</given-names>
</name>
<name>
<surname>Altan</surname> <given-names>N</given-names>
</name>
<name>
<surname>Aslan</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidant/antioxidant balance in patients with thyroid cancer</article-title>. <source>Acta Cir Bras</source> (<year>2008</year>) <volume>23</volume>:<page-range>551&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/s0102-86502008000600013</pub-id>
</citation>
</ref>
<ref id="B125">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lassoued</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mseddi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mnif</surname> <given-names>F</given-names>
</name>
<name>
<surname>Abid</surname> <given-names>M</given-names>
</name>
<name>
<surname>Guermazi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Masmoudi</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>A comparative study of the oxidative profile in graves&#x2019; disease, hashimoto&#x2019;s thyroiditis, and papillary thyroid cancer</article-title>. <source>Biol Trace Elem Res</source> (<year>2010</year>) <volume>138</volume>:<page-range>107&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12011-010-8625-1</pub-id>
</citation>
</ref>
<ref id="B126">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matrone</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ferrari</surname> <given-names>F</given-names>
</name>
<name>
<surname>Santini</surname> <given-names>F</given-names>
</name>
<name>
<surname>Elisei</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Obesity as a risk factor for thyroid cancer</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source> (<year>2020</year>) <volume>27</volume>:<page-range>358&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/med.0000000000000556</pub-id>
</citation>
</ref>
<ref id="B127">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Clinicopathological features and prognosis of papillary thyroid cancer patients with type 2 diabetes mellitus</article-title>. <source>Gland Surg</source> (<year>2022</year>) <volume>11</volume>:<page-range>358&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/gs-21-905</pub-id>
</citation>
</ref>
<ref id="B128">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziros</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Habeos</surname> <given-names>IG</given-names>
</name>
<name>
<surname>Chartoumpekis</surname> <given-names>DV</given-names>
</name>
<name>
<surname>Ntalampyra</surname> <given-names>E</given-names>
</name>
<name>
<surname>Somm</surname> <given-names>E</given-names>
</name>
<name>
<surname>Renaud</surname> <given-names>CO</given-names>
</name>
<etal/>
</person-group>. <article-title>NFE2-related transcription factor 2 coordinates antioxidant defense with thyroglobulin production and iodination in the thyroid gland</article-title>. <source>Thyroid</source> (<year>2018</year>) <volume>28</volume>:<page-range>780&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2018.0018</pub-id>
</citation>
</ref>
<ref id="B129">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renaud</surname> <given-names>CO</given-names>
</name>
<name>
<surname>Ziros</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Chartoumpekis</surname> <given-names>DV</given-names>
</name>
<name>
<surname>Bongiovanni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sykiotis</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>Keap1/Nrf2 signaling: A new player in thyroid pathophysiology and thyroid cancer</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>510</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2019.00510</pub-id>
</citation>
</ref>
<ref id="B130">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leinonen</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Kansanen</surname> <given-names>E</given-names>
</name>
<name>
<surname>P&#xf6;l&#xf6;nen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Hein&#xe4;niemi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Levonen</surname> <given-names>AL</given-names>
</name>
</person-group>. <article-title>Role of the Keap1-Nrf2 pathway in cancer</article-title>. <source>Adv Cancer Res</source> (<year>2014</year>) <volume>122</volume>:<fpage>281</fpage>&#x2013;<lpage>320</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/b978-0-12-420117-0.00008-6</pub-id>
</citation>
</ref>
<ref id="B131">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Takano</surname> <given-names>T</given-names>
</name>
<name>
<surname>Miyauchi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Matsuzuka</surname> <given-names>F</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kuma</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma</article-title>. <source>Cancer Lett</source> (<year>2002</year>) <volume>182</volume>:<fpage>69</fpage>&#x2013;<lpage>74</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0304-3835(02)00069-1</pub-id>
</citation>
</ref>
<ref id="B132">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cazarin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dupuy</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pires de Carvalho</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Redox homeostasis in thyroid cancer: Implications in Na(+)/I(-) symporter (NIS) regulation</article-title>. <source>Int J Mol Sci</source> (<year>2022</year>) <volume>23</volume>:<elocation-id>6129</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23116129</pub-id>
</citation>
</ref>
<ref id="B133">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cena</surname> <given-names>H</given-names>
</name>
<name>
<surname>Calder</surname> <given-names>PC</given-names>
</name>
</person-group>. <article-title>Defining a healthy diet: Evidence for the role of contemporary dietary patterns in health and disease</article-title>. <source>Nutrients</source> (<year>2020</year>) <volume>12</volume>:<elocation-id>334</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12020334</pub-id>
</citation>
</ref>
<ref id="B134">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garc&#xed;a-Garc&#xed;a</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Monistrol-Mula</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cardellach</surname> <given-names>F</given-names>
</name>
<name>
<surname>Garrabou</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Nutrition, bioenergetics, and metabolic syndrome</article-title>. <source>Nutrients</source> (<year>2020</year>) <volume>12</volume>:<elocation-id>2785</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12092785</pub-id>
</citation>
</ref>
<ref id="B135">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rakhra</surname> <given-names>V</given-names>
</name>
<name>
<surname>Galappaththy</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Bulchandani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cabandugama</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Obesity and the Western diet: How we got here</article-title>. <source>Mo Med</source> (<year>2020</year>) <volume>117</volume>:<page-range>536&#x2013;8</page-range>.</citation>
</ref>
<ref id="B136">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Norhaizan</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Liew</surname> <given-names>WP</given-names>
</name>
</person-group>. <article-title>Nutrients and oxidative stress: Friend or foe</article-title>? <source>Oxid Med Cell Longev</source> (<year>2018</year>) <volume>2018</volume>:<elocation-id>9719584</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2018/9719584</pub-id>
</citation>
</ref>
<ref id="B137">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haeiwa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Fujita</surname> <given-names>T</given-names>
</name>
<name>
<surname>Saitoh</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Miwa</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Oleic acid promotes adaptability against oxidative stress in 3T3-L1 cells through lipohormesis</article-title>. <source>Mol Cell Biochem</source> (<year>2014</year>) <volume>386</volume>:<fpage>73</fpage>&#x2013;<lpage>83</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11010-013-1846-9</pub-id>
</citation>
</ref>
<ref id="B138">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravaut</surname> <given-names>G</given-names>
</name>
<name>
<surname>L&#xe9;giot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bergeron</surname> <given-names>KF</given-names>
</name>
</person-group>. <article-title>Monounsaturated fatty acids in obesity-related inflammation</article-title>. <source>Int J Mol Sci</source> (<year>2020</year>) <volume>22</volume>:<elocation-id>330</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22010330</pub-id>
</citation>
</ref>
<ref id="B139">
<label>139</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva Figueiredo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Carla Inada</surname> <given-names>A</given-names>
</name>
<name>
<surname>Marcelino</surname> <given-names>G</given-names>
</name>
<name>
<surname>Maiara Lopes Cardozo</surname> <given-names>C</given-names>
</name>
<name>
<surname>de C&#xe1;ssia Freitas</surname> <given-names>K</given-names>
</name>
<name>
<surname>de C&#xe1;ssia Avellaneda Guimar&#xe3;es</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Fatty acids consumption: The role metabolic aspects involved in obesity and its associated disorders</article-title>. <source>Nutrients</source> (<year>2017</year>) <volume>9</volume>:<elocation-id>1158</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu9101158</pub-id>
</citation>
</ref>
<ref id="B140">
<label>140</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meital</surname> <given-names>LT</given-names>
</name>
<name>
<surname>Windsor</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Perissiou</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schulze</surname> <given-names>K</given-names>
</name>
<name>
<surname>Magee</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kuballa</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>:<fpage>12978</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-019-49362-z</pub-id>
</citation>
</ref>
<ref id="B141">
<label>141</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simopoulos</surname> <given-names>AP</given-names>
</name>
</person-group>. <article-title>The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases</article-title>. <source>Exp Biol Med (Maywood)</source> (<year>2008</year>) <volume>233</volume>:<page-range>674&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3181/0711-mr-311</pub-id>
</citation>
</ref>
<ref id="B142">
<label>142</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Resveratrol attenuates oxidative stress and extends life span in the annual fish nothobranchius guentheri</article-title>. <source>Rejuvenation Res</source> (<year>2015</year>) <volume>18</volume>:<page-range>225&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/rej.2014.1618</pub-id>
</citation>
</ref>
<ref id="B143">
<label>143</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonnefont-Rousselot</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Resveratrol and cardiovascular diseases</article-title>. <source>Nutrients</source> (<year>2016</year>) <volume>8</volume>:<elocation-id>250</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu8050250</pub-id>
</citation>
</ref>
<ref id="B144">
<label>144</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dyck</surname> <given-names>GJB</given-names>
</name>
<name>
<surname>Raj</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zieroth</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dyck</surname> <given-names>JRB</given-names>
</name>
<name>
<surname>Ezekowitz</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>The effects of resveratrol in patients with cardiovascular disease and heart failure: A narrative review</article-title>. <source>Int J Mol Sci</source> (<year>2019</year>) <volume>20</volume>:<elocation-id>904</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms20040904</pub-id>
</citation>
</ref>
<ref id="B145">
<label>145</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Lau</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>ZY</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>XY</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Pharmacological basis and new insights of resveratrol action in the cardiovascular system</article-title>. <source>Br J Pharmacol</source> (<year>2020</year>) <volume>177</volume>:<page-range>1258&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/bph.14801</pub-id>
</citation>
</ref>
<ref id="B146">
<label>146</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ciccone</surname> <given-names>G</given-names>
</name>
<name>
<surname>Castiglione</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gambino</surname> <given-names>R</given-names>
</name>
<name>
<surname>De Michieli</surname> <given-names>F</given-names>
</name>
<name>
<surname>Villois</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial</article-title>. <source>Curr Med Chem</source> (<year>2013</year>) <volume>20</volume>:<page-range>1323&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/0929867311320100009</pub-id>
</citation>
</ref>
<ref id="B147">
<label>147</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szkudelska</surname> <given-names>K</given-names>
</name>
<name>
<surname>Okulicz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hertig</surname> <given-names>I</given-names>
</name>
<name>
<surname>Szkudelski</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Resveratrol ameliorates inflammatory and oxidative stress in type 2 diabetic goto-kakizaki rats</article-title>. <source>BioMed Pharmacother</source> (<year>2020</year>) <volume>125</volume>:<elocation-id>110026</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2020.110026</pub-id>
</citation>
</ref>
<ref id="B148">
<label>148</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>XQ</given-names>
</name>
</person-group>. <article-title>Antioxidant and anti-inflammatory properties of resveratrol in diabetic nephropathy: A systematic review and meta-analysis of animal studies</article-title>. <source>Front Pharmacol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>841818</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.841818</pub-id>
</citation>
</ref>
<ref id="B149">
<label>149</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahjabeen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Mirza</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial</article-title>. <source>Complement Ther Med</source> (<year>2022</year>) <volume>66</volume>:<elocation-id>102819</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ctim.2022.102819</pub-id>
</citation>
</ref>
<ref id="B150">
<label>150</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Resveratrol in treating diabetes and its cardiovascular complications: A review of its mechanisms of action</article-title>. <source>Antioxidants (Basel)</source> (<year>2022</year>) <volume>11</volume>:<elocation-id>1085</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox11061085</pub-id>
</citation>
</ref>
<ref id="B151">
<label>151</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Bhardwaj</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aggarwal</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Seeram</surname> <given-names>NP</given-names>
</name>
<name>
<surname>Shishodia</surname> <given-names>S</given-names>
</name>
<name>
<surname>Takada</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies</article-title>. <source>Anticancer Res</source> (<year>2004</year>) <volume>24</volume>:<page-range>2783&#x2013;840</page-range>.</citation>
</ref>
<ref id="B152">
<label>152</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauf</surname> <given-names>A</given-names>
</name>
<name>
<surname>Imran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Butt</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Nadeem</surname> <given-names>M</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Mubarak</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Resveratrol as an anti-cancer agent: A review</article-title>. <source>Crit Rev Food Sci Nutr</source> (<year>2018</year>) <volume>58</volume>:<page-range>1428&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408398.2016.1263597</pub-id>
</citation>
</ref>
<ref id="B153">
<label>153</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rotondo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rajtar</surname> <given-names>G</given-names>
</name>
<name>
<surname>Manarini</surname> <given-names>S</given-names>
</name>
<name>
<surname>Celardo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rotillo</surname> <given-names>D</given-names>
</name>
<name>
<surname>de Gaetano</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function</article-title>. <source>Br J Pharmacol</source> (<year>1998</year>) <volume>123</volume>:<page-range>1691&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.bjp.0701784</pub-id>
</citation>
</ref>
<ref id="B154">
<label>154</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizutani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ikeda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kawai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yamori</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats</article-title>. <source>Clin Exp Pharmacol Physiol</source> (<year>2001</year>) <volume>28</volume>:<page-range>55&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1440-1681.2001.03415.x</pub-id>
</citation>
</ref>
<ref id="B155">
<label>155</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belguendouz</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fr&#xe9;mont</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gozzelino</surname> <given-names>MT</given-names>
</name>
</person-group>. <article-title>Interaction of transresveratrol with plasma lipoproteins</article-title>. <source>Biochem Pharmacol</source> (<year>1998</year>) <volume>55</volume>:<page-range>811&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0006-2952(97)00544-3</pub-id>
</citation>
</ref>
<ref id="B156">
<label>156</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wenzel</surname> <given-names>E</given-names>
</name>
<name>
<surname>Soldo</surname> <given-names>T</given-names>
</name>
<name>
<surname>Erbersdobler</surname> <given-names>H</given-names>
</name>
<name>
<surname>Somoza</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Bioactivity and metabolism of trans-resveratrol orally administered to wistar rats</article-title>. <source>Mol Nutr Food Res</source> (<year>2005</year>) <volume>49</volume>:<page-range>482&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mnfr.200500003</pub-id>
</citation>
</ref>
<ref id="B157">
<label>157</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delmas</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jannin</surname> <given-names>B</given-names>
</name>
<name>
<surname>Latruffe</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Resveratrol: preventing properties against vascular alterations and ageing</article-title>. <source>Mol Nutr Food Res</source> (<year>2005</year>) <volume>49</volume>:<page-range>377&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mnfr.200400098</pub-id>
</citation>
</ref>
<ref id="B158">
<label>158</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacCarrone</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lorenzon</surname> <given-names>T</given-names>
</name>
<name>
<surname>Guerrieri</surname> <given-names>P</given-names>
</name>
<name>
<surname>Agr&#xf2;</surname> <given-names>AF</given-names>
</name>
</person-group>. <article-title>Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity</article-title>. <source>Eur J Biochem</source> (<year>1999</year>) <volume>265</volume>:<fpage>27</fpage>&#x2013;<lpage>34</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1432-1327.1999.00630.x</pub-id>
</citation>
</ref>
<ref id="B159">
<label>159</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonard</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Stinefelt</surname> <given-names>B</given-names>
</name>
<name>
<surname>Klandorf</surname> <given-names>H</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>GK</given-names>
</name>
<etal/>
</person-group>. <article-title>Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2003</year>) <volume>309</volume>:<page-range>1017&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2003.08.105</pub-id>
</citation>
</ref>
<ref id="B160">
<label>160</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anand</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kunnumakkara</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Newman</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Aggarwal</surname> <given-names>BB</given-names>
</name>
</person-group>. <article-title>Bioavailability of curcumin: problems and promises</article-title>. <source>Mol Pharm</source> (<year>2007</year>) <volume>4</volume>:<page-range>807&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/mp700113r</pub-id>
</citation>
</ref>
<ref id="B161">
<label>161</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharifi-Rad</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rayess</surname> <given-names>YE</given-names>
</name>
<name>
<surname>Rizk</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Sadaka</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zgheib</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zam</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications</article-title>. <source>Front Pharmacol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>1021</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2020.01021</pub-id>
</citation>
</ref>
<ref id="B162">
<label>162</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ghosh</surname> <given-names>R</given-names>
</name>
<name>
<surname>Charcosset</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Extraction, purification and applications of curcumin from plant materials-a comprehensive review</article-title>. <source>Trends Food Sci Technol</source> (<year>2021</year>) <volume>112</volume>:<page-range>419&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tifs.2021.04.015</pub-id>
</citation>
</ref>
<ref id="B163">
<label>163</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>X</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway</article-title>. <source>PloS One</source> (<year>2019</year>) <volume>14</volume>:<elocation-id>e0216711</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0216711</pub-id>
</citation>
</ref>
<ref id="B164">
<label>164</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menon</surname> <given-names>VP</given-names>
</name>
<name>
<surname>Sudheer</surname> <given-names>AR</given-names>
</name>
</person-group>. <article-title>Antioxidant and anti-inflammatory properties of curcumin</article-title>. <source>Adv Exp Med Biol</source> (<year>2007</year>) <volume>595</volume>:<page-range>105&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-0-387-46401-5_3</pub-id>
</citation>
</ref>
<ref id="B165">
<label>165</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maithili Karpaga Selvi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Sridhar</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Swaminathan</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Sripradha</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Curcumin attenuates oxidative stress and activation of redox-sensitive kinases in high fructose- and high-Fat-Fed Male wistar rats</article-title>. <source>Sci Pharm</source> (<year>2015</year>) <volume>83</volume>:<page-range>159&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3797/scipharm.1408-16</pub-id>
</citation>
</ref>
<ref id="B166">
<label>166</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neag</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Mocan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Echeverria</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pop</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Bocsan</surname> <given-names>CI</given-names>
</name>
<name>
<surname>Crisan</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders</article-title>. <source>Front Pharmacol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>557</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2018.00557</pub-id>
</citation>
</ref>
<ref id="B167">
<label>167</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>YN</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus</article-title>. <source>Evid Based Complement Alternat Med</source> (<year>2014</year>) <volume>2014</volume>:<fpage>289264</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2014/289264</pub-id>
</citation>
</ref>
<ref id="B168">
<label>168</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>RY</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The effective role of natural product berberine in modulating oxidative stress and inflammation related atherosclerosis: Novel insights into the gut-heart axis evidenced by genetic sequencing analysis</article-title>. <source>Front Pharmacol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>764994</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2021.764994</pub-id>
</citation>
</ref>
<ref id="B169">
<label>169</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>The pathogenesis of diabetes mellitus by oxidative stress and inflammation: Its inhibition by berberine</article-title>. <source>Front Pharmacol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>782</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2018.00782</pub-id>
</citation>
</ref>
<ref id="B170">
<label>170</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzino</surname> <given-names>G</given-names>
</name>
<name>
<surname>Irrera</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cucinotta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pallio</surname> <given-names>G</given-names>
</name>
<name>
<surname>Mannino</surname> <given-names>F</given-names>
</name>
<name>
<surname>Arcoraci</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Oxidative stress: Harms and benefits for human health</article-title>. <source>Oxid Med Cell Longev</source> (<year>2017</year>) <volume>2017</volume>:<elocation-id>8416763</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/8416763</pub-id>
</citation>
</ref>
<ref id="B171">
<label>171</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aceves</surname> <given-names>C</given-names>
</name>
<name>
<surname>Anguiano</surname> <given-names>B</given-names>
</name>
<name>
<surname>Delgado</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues</article-title>. <source>Thyroid</source> (<year>2013</year>) <volume>23</volume>:<page-range>938&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2012.0579</pub-id>
</citation>
</ref>
<ref id="B172">
<label>172</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zicker</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schoenherr</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Focus on nutrition: the role of iodine in nutrition and metabolism</article-title>. <source>Compend Contin Educ Vet</source> (<year>2012</year>) <volume>34</volume>:<page-range>E1&#x2013;4</page-range>.</citation>
</ref>
<ref id="B173">
<label>173</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hendryx</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dinh</surname> <given-names>P</given-names>
</name>
<name>
<surname>He</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Association of iodine and iron with thyroid function</article-title>. <source>Biol Trace Elem Res</source> (<year>2017</year>) <volume>179</volume>:<fpage>38</fpage>&#x2013;<lpage>44</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12011-017-0954-x</pub-id>
</citation>
</ref>
<ref id="B174">
<label>174</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmermann</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Galetti</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies</article-title>. <source>Thyroid Res</source> (<year>2015</year>) <volume>8</volume>:<elocation-id>8</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13044-015-0020-8</pub-id>
</citation>
</ref>
<ref id="B175">
<label>175</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolff</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chaikoff</surname> <given-names>IL</given-names>
</name>
</person-group>. <article-title>Plasma inorganic iodide as a homeostatic regulator of thyroid function</article-title>. <source>J Biol Chem</source> (<year>1948</year>) <volume>174</volume>:<page-range>555&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(18)57335-X</pub-id>
</citation>
</ref>
<ref id="B176">
<label>176</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leung</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Braverman</surname> <given-names>LE</given-names>
</name>
</person-group>. <article-title>Consequences of excess iodine</article-title>. <source>Nat Rev Endocrinol</source> (<year>2014</year>) <volume>10</volume>:<page-range>136&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrendo.2013.251</pub-id>
</citation>
</ref>
<ref id="B177">
<label>177</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Civitareale</surname> <given-names>D</given-names>
</name>
<name>
<surname>Saiardi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Falasca</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Purification and characterization of thyroid transcription factor 2</article-title>. <source>Biochem J</source> (<year>1994</year>) <volume>304</volume>(<issue>Pt 3</issue>):<page-range>981&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bj3040981</pub-id>
</citation>
</ref>
<ref id="B178">
<label>178</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severo</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Morais</surname> <given-names>JBS</given-names>
</name>
<name>
<surname>de Freitas</surname> <given-names>TEC</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>ALP</given-names>
</name>
<name>
<surname>Feitosa</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Fontenelle</surname> <given-names>LC</given-names>
</name>
<etal/>
</person-group>. <article-title>The role of zinc in thyroid hormones metabolism</article-title>. <source>Int J Vitam Nutr Res</source> (<year>2019</year>) <volume>89</volume>:<page-range>80&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1024/0300-9831/a000262</pub-id>
</citation>
</ref>
<ref id="B179">
<label>179</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kralik</surname> <given-names>A</given-names>
</name>
<name>
<surname>Eder</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kirchgessner</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Influence of zinc and selenium deficiency on parameters relating to thyroid hormone metabolism</article-title>. <source>Horm Metab Res</source> (<year>1996</year>) <volume>28</volume>:<page-range>223&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-2007-979169</pub-id>
</citation>
</ref>
<ref id="B180">
<label>180</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kawate</surname> <given-names>R</given-names>
</name>
<name>
<surname>Usui</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Zinc metabolism in thyroid disease</article-title>. <source>Postgrad Med J</source> (<year>1980</year>) <volume>56</volume>:<page-range>833&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/pgmj.56.662.833</pub-id>
</citation>
</ref>
<ref id="B181">
<label>181</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drutel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Archambeaud</surname> <given-names>F</given-names>
</name>
<name>
<surname>Caron</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Selenium and the thyroid gland: more good news for clinicians</article-title>. <source>Clin Endocrinol (Oxf)</source> (<year>2013</year>) <volume>78</volume>:<page-range>155&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cen.12066</pub-id>
</citation>
</ref>
<ref id="B182">
<label>182</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;hrle</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Selenium and the thyroid</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source> (<year>2013</year>) <volume>20</volume>:<page-range>441&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/01.med.0000433066.24541.88</pub-id>
</citation>
</ref>
<ref id="B183">
<label>183</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoidis</surname> <given-names>E</given-names>
</name>
<name>
<surname>Seremelis</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kontopoulos</surname> <given-names>N</given-names>
</name>
<name>
<surname>Danezis</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>Selenium-dependent antioxidant enzymes: Actions and properties of selenoproteins</article-title>. <source>Antioxidants (Basel)</source> (<year>2018</year>) <volume>7</volume>:<elocation-id>66</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox7050066</pub-id>
</citation>
</ref>
<ref id="B184">
<label>184</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giuliani</surname> <given-names>C</given-names>
</name>
<name>
<surname>Iezzi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ciolli</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hysi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bucci</surname> <given-names>I</given-names>
</name>
<name>
<surname>Di Santo</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Resveratrol has anti-thyroid effects both in vitro and in vivo</article-title>. <source>Food Chem Toxicol</source> (<year>2017</year>) <volume>107</volume>:<page-range>237&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2017.06.044</pub-id>
</citation>
</ref>
<ref id="B185">
<label>185</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Cen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ou</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huo</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>The potential prebiotic berberine combined with methimazole improved the therapeutic effect of graves&#x2019; disease patients through regulating the intestinal microbiome</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>826067</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.826067</pub-id>
</citation>
</ref>
<ref id="B186">
<label>186</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lakshmanan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Trimarchi</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake</article-title>. <source>Thyroid</source> (<year>2000</year>) <volume>10</volume>:<page-range>1043&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2000.10.1043</pub-id>
</citation>
</ref>
<ref id="B187">
<label>187</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nordio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lagan&#xe0;</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Unfer</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>The role of inositol in thyroid physiology and in subclinical hypothyroidism management</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>662582</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2021.662582</pub-id>
</citation>
</ref>
<ref id="B188">
<label>188</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spaggiari</surname> <given-names>G</given-names>
</name>
<name>
<surname>Brigante</surname> <given-names>G</given-names>
</name>
<name>
<surname>De Vincentis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cattini</surname> <given-names>U</given-names>
</name>
<name>
<surname>Roli</surname> <given-names>L</given-names>
</name>
<name>
<surname>De Santis</surname> <given-names>MC</given-names>
</name>
<etal/>
</person-group>. <article-title>Probiotics ingestion does not directly affect thyroid hormonal parameters in hypothyroid patients on levothyroxine treatment</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>316</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2017.00316</pub-id>
</citation>
</ref>
<ref id="B189">
<label>189</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fr&#xf6;hlich</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wahl</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Microbiota and thyroid interaction in health and disease</article-title>. <source>Trends Endocrinol Metab</source> (<year>2019</year>) <volume>30</volume>:<page-range>479&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tem.2019.05.008</pub-id>
</citation>
</ref>
<ref id="B190">
<label>190</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kie&#x142;czykowska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kocot</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pa&#x17a;dzior</surname> <given-names>M</given-names>
</name>
<name>
<surname>Musik</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Selenium - a fascinating antioxidant of protective properties</article-title>. <source>Adv Clin Exp Med</source> (<year>2018</year>) <volume>27</volume>:<page-range>245&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.17219/acem/67222</pub-id>
</citation>
</ref>
<ref id="B191">
<label>191</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rayman</surname> <given-names>MP</given-names>
</name>
</person-group>. <article-title>Multiple nutritional factors and the risk of hashimoto&#x2019;s thyroiditis</article-title>. <source>Thyroid</source> (<year>2017</year>) <volume>27</volume>:<fpage>597</fpage>&#x2013;<lpage>610</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2016.0635</pub-id>
</citation>
</ref>
<ref id="B192">
<label>192</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Schomburg</surname> <given-names>L</given-names>
</name>
<name>
<surname>K&#xf6;hrle</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pedersen</surname> <given-names>IB</given-names>
</name>
<name>
<surname>Hollenbach</surname> <given-names>B</given-names>
</name>
<name>
<surname>H&#xf6;g</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency</article-title>. <source>Eur J Endocrinol</source> (<year>2011</year>) <volume>164</volume>:<page-range>585&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/eje-10-1026</pub-id>
</citation>
</ref>
<ref id="B193">
<label>193</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Rose</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>PR</given-names>
</name>
</person-group>. <article-title>The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities</article-title>. <source>Antioxid Redox Signal</source> (<year>2012</year>) <volume>16</volume>:<page-range>705&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2011.4145</pub-id>
</citation>
</ref>
<ref id="B194">
<label>194</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toulis</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Anastasilakis</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Tzellos</surname> <given-names>TG</given-names>
</name>
<name>
<surname>Goulis</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Kouvelas</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Selenium supplementation in the treatment of hashimoto&#x2019;s thyroiditis: a systematic review and a meta-analysis</article-title>. <source>Thyroid</source> (<year>2010</year>) <volume>20</volume>:<page-range>1163&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2009.0351</pub-id>
</citation>
</ref>
<ref id="B195">
<label>195</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzulli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ranjbar</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Selenium deficiency and hypothyroidism: a new etiology in the differential diagnosis of hypothyroidism in children</article-title>. <source>Biol Trace Elem Res</source> (<year>2000</year>) <volume>77</volume>:<fpage>199</fpage>&#x2013;<lpage>208</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1385/bter:77:3:199</pub-id>
</citation>
</ref>
<ref id="B196">
<label>196</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burk</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>KE</given-names>
</name>
</person-group>. <article-title>Regulation of selenium metabolism and transport</article-title>. <source>Annu Rev Nutr</source> (<year>2015</year>) <volume>35</volume>:<page-range>109&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-nutr-071714-034250</pub-id>
</citation>
</ref>
<ref id="B197">
<label>197</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hovs&#xe9;pian</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ristorcelli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Aouani</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lombardo</surname> <given-names>D</given-names>
</name>
<name>
<surname>Fayet</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5</article-title>. <source>Thyroid</source> (<year>2010</year>) <volume>20</volume>:<fpage>195</fpage>&#x2013;<lpage>203</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/thy.2009.0171</pub-id>
</citation>
</ref>
<ref id="B198">
<label>198</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shih</surname> <given-names>A</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>FB</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>PJ</given-names>
</name>
</person-group>. <article-title>Resveratrol induces apoptosis in thyroid cancer cell lines <italic>via</italic> a MAPK- and p53-dependent mechanism</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2002</year>) <volume>87</volume>:<page-range>1223&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jcem.87.3.8345</pub-id>
</citation>
</ref>
<ref id="B199">
<label>199</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Truong</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cook</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Pinchot</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Kunnimalaiyaan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer</article-title>. <source>Ann Surg Oncol</source> (<year>2011</year>) <volume>18</volume>:<page-range>1506&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1245/s10434-010-1488-z</pub-id>
</citation>
</ref>
<ref id="B200">
<label>200</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Antonelli</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Inositol(s) in thyroid function, growth and autoimmunity</article-title>. <source>Rev Endocr Metab Disord</source> (<year>2016</year>) <volume>17</volume>:<page-range>471&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11154-016-9370-3</pub-id>
</citation>
</ref>
<ref id="B201">
<label>201</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pajalich</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Combined treatment with myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis</article-title>. <source>J Thyroid Res</source> (<year>2013</year>) <volume>2013</volume>:<elocation-id>424163</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2013/424163</pub-id>
</citation>
</ref>
<ref id="B202">
<label>202</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paparo</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Ferrari</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Patrizio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Elia</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ragusa</surname> <given-names>F</given-names>
</name>
<name>
<surname>Botrini</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Myoinositol in autoimmune thyroiditis</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>930756</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.930756</pub-id>
</citation>
</ref>
<ref id="B203">
<label>203</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Basciani</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Treatment with myo-inositol and selenium ensures euthyroidism in patients with autoimmune thyroiditis</article-title>. <source>Int J Endocrinol</source> (<year>2017</year>) <volume>2017</volume>:<elocation-id>2549491</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/2549491</pub-id>
</citation>
</ref>
<ref id="B204">
<label>204</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Basciani</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Myo-inositol plus selenium supplementation restores euthyroid state in hashimoto&#x2019;s patients with subclinical hypothyroidism</article-title>. <source>Eur Rev Med Pharmacol Sci</source> (<year>2017</year>) <volume>21</volume>:<page-range>51&#x2013;9</page-range>.</citation>
</ref>
<ref id="B205">
<label>205</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nordio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Basciani</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment</article-title>. <source>Eur Rev Med Pharmacol Sci</source> (<year>2018</year>) <volume>22</volume>:<page-range>2153&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.26355/eurrev_201804_14749</pub-id>
</citation>
</ref>
<ref id="B206">
<label>206</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pekala</surname> <given-names>J</given-names>
</name>
<name>
<surname>Patkowska-Soko&#x142;a</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bodkowski</surname> <given-names>R</given-names>
</name>
<name>
<surname>Jamroz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Nowakowski</surname> <given-names>P</given-names>
</name>
<name>
<surname>Lochy&#x144;ski</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>L-carnitine&#x2013;metabolic functions and meaning in humans life</article-title>. <source>Curr Drug Metab</source> (<year>2011</year>) <volume>12</volume>:<page-range>667&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/138920011796504536</pub-id>
</citation>
</ref>
<ref id="B207">
<label>207</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xfc;l&#xe7;in</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Antioxidant and antiradical activities of l-carnitine</article-title>. <source>Life Sci</source> (<year>2006</year>) <volume>78</volume>:<page-range>803&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2005.05.103</pub-id>
</citation>
</ref>
<ref id="B208">
<label>208</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>ZY</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>CY</given-names>
</name>
</person-group>. <article-title>L-carnitine and heart disease</article-title>. <source>Life Sci</source> (<year>2018</year>) <volume>194</volume>:<fpage>88</fpage>&#x2013;<lpage>97</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2017.12.015</pub-id>
</citation>
</ref>
<ref id="B209">
<label>209</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gnoni</surname> <given-names>A</given-names>
</name>
<name>
<surname>Longo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gnoni</surname> <given-names>GV</given-names>
</name>
<name>
<surname>Giudetti</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>Carnitine in human muscle bioenergetics: Can carnitine supplementation improve physical exercise</article-title>? <source>Molecules</source> (<year>2020</year>) <volume>25</volume>:<elocation-id>182</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules25010182</pub-id>
</citation>
</ref>
<ref id="B210">
<label>210</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ruggeri</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Russo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lapa</surname> <given-names>D</given-names>
</name>
<name>
<surname>Campenni</surname> <given-names>A</given-names>
</name>
<name>
<surname>Trimarchi</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Usefulness of l-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2001</year>) <volume>86</volume>:<page-range>3579&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jcem.86.8.7747</pub-id>
</citation>
</ref>
<ref id="B211">
<label>211</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lapa</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cannav&#xf2;</surname> <given-names>S</given-names>
</name>
<name>
<surname>Trimarchi</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Successive thyroid storms treated with l-carnitine and low doses of methimazole</article-title>. <source>Am J Med</source> (<year>2003</year>) <volume>115</volume>:<page-range>417&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0002-9343(03)00399-1</pub-id>
</citation>
</ref>
<ref id="B212">
<label>212</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimmoun</surname> <given-names>A</given-names>
</name>
<name>
<surname>Munagamage</surname> <given-names>G</given-names>
</name>
<name>
<surname>Dessalles</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gerard</surname> <given-names>A</given-names>
</name>
<name>
<surname>Feillet</surname> <given-names>F</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Unexpected awakening from comatose thyroid storm after a single intravenous injection of l-carnitine</article-title>. <source>Intensive Care Med</source> (<year>2011</year>) <volume>37</volume>:<page-range>1716&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00134-011-2293-2</pub-id>
</citation>
</ref>
<ref id="B213">
<label>213</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chee</surname> <given-names>R</given-names>
</name>
<name>
<surname>Agah</surname> <given-names>R</given-names>
</name>
<name>
<surname>Vita</surname> <given-names>R</given-names>
</name>
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>L-carnitine treatment in a seriously ill cancer patient with severe hyperthyroidism</article-title>. <source>Hormones (Athens)</source> (<year>2014</year>) <volume>13</volume>:<page-range>407&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14310/horm.2002.1494</pub-id>
</citation>
</ref>
<ref id="B214">
<label>214</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maebashi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kawamura</surname> <given-names>N</given-names>
</name>
<name>
<surname>Sato</surname> <given-names>M</given-names>
</name>
<name>
<surname>Imamura</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yoshinaga</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: augmentation by thyroid hormone</article-title>. <source>Metabolism</source> (<year>1977</year>) <volume>26</volume>:<page-range>351&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0026-0495(77)90101-9</pub-id>
</citation>
</ref>
<ref id="B215">
<label>215</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinclair</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gilchrist</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Hennessey</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Kandula</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Muscle carnitine in hypo- and hyperthyroidism</article-title>. <source>Muscle Nerve</source> (<year>2005</year>) <volume>32</volume>:<page-range>357&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mus.20336</pub-id>
</citation>
</ref>
<ref id="B216">
<label>216</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>NH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HY</given-names>
</name>
<etal/>
</person-group>. <article-title>L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Endocr J</source> (<year>2016</year>) <volume>63</volume>:<page-range>885&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1507/endocrj.EJ16-0109</pub-id>
</citation>
</ref>
<ref id="B217">
<label>217</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname> <given-names>C</given-names>
</name>
<name>
<surname>Guarner</surname> <given-names>F</given-names>
</name>
<name>
<surname>Reid</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gibson</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Merenstein</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Pot</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Expert consensus document. the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic</article-title>. <source>Nat Rev Gastroenterol Hepatol</source> (<year>2014</year>) <volume>11</volume>:<page-range>506&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrgastro.2014.66</pub-id>
</citation>
</ref>
<ref id="B218">
<label>218</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname> <given-names>V</given-names>
</name>
<name>
<surname>Shah</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mokashe</surname> <given-names>N</given-names>
</name>
<name>
<surname>Chavan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yadav</surname> <given-names>H</given-names>
</name>
<name>
<surname>Prajapati</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Probiotics as potential antioxidants: a systematic review</article-title>. <source>J Agric Food Chem</source> (<year>2015</year>) <volume>63</volume>:<page-range>3615&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/jf506326t</pub-id>
</citation>
</ref>
<ref id="B219">
<label>219</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Bueno</surname> <given-names>AA</given-names>
</name>
<name>
<surname>de Souza</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Mota</surname> <given-names>JF</given-names>
</name>
</person-group>. <article-title>Gut microbiota, probiotics and diabetes</article-title>. <source>Nutr J</source> (<year>2014</year>) <volume>13</volume>:<elocation-id>60</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1475-2891-13-60</pub-id>
</citation>
</ref>
<ref id="B220">
<label>220</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Derrien</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rocher</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice</article-title>. <source>Isme J</source> (<year>2015</year>) <volume>9</volume>:<fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ismej.2014.99</pub-id>
</citation>
</ref>
<ref id="B221">
<label>221</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rad</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Abbasalizadeh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vazifekhah</surname> <given-names>S</given-names>
</name>
<name>
<surname>Abbasalizadeh</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hassanalilou</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bastani</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The future of diabetes management by healthy probiotic microorganisms</article-title>. <source>Curr Diabetes Rev</source> (<year>2017</year>) <volume>13</volume>:<page-range>582&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1573399812666161014112515</pub-id>
</citation>
</ref>
<ref id="B222">
<label>222</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asemi</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zare</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shakeri</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sabihi</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Esmaillzadeh</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes</article-title>. <source>Ann Nutr Metab</source> (<year>2013</year>) <volume>63</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000349922</pub-id>
</citation>
</ref>
<ref id="B223">
<label>223</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Antioxidant properties of probiotic bacteria</article-title>. <source>Nutrients</source> (<year>2017</year>) <volume>9</volume>:<elocation-id>521</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu9050521</pub-id>
</citation>
</ref>
<ref id="B224">
<label>224</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>AN</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>XW</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>B</given-names>
</name>
<name>
<surname>Qiao</surname> <given-names>SY</given-names>
</name>
</person-group>. <article-title>Free radical scavenging activity of lactobacillus fermentum <italic>in vitro</italic> and its antioxidative effect on growing-finishing pigs</article-title>. <source>J Appl Microbiol</source> (<year>2009</year>) <volume>107</volume>:<page-range>1140&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2672.2009.04294.x</pub-id>
</citation>
</ref>
<ref id="B225">
<label>225</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stecchini</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Del Torre</surname> <given-names>M</given-names>
</name>
<name>
<surname>Munari</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Determination of peroxy radical-scavenging of lactic acid bacteria</article-title>. <source>Int J Food Microbiol</source> (<year>2001</year>) <volume>64</volume>:<page-range>183&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0168-1605(00)00456-6</pub-id>
</citation>
</ref>
<ref id="B226">
<label>226</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kullisaar</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zilmer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mikelsaar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vihalemm</surname> <given-names>T</given-names>
</name>
<name>
<surname>Annuk</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kairane</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Two antioxidative lactobacilli strains as promising probiotics</article-title>. <source>Int J Food Microbiol</source> (<year>2002</year>) <volume>72</volume>:<page-range>215&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0168-1605(01)00674-2</pub-id>
</citation>
</ref>
<ref id="B227">
<label>227</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ejtahed</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Mohtadi-Nia</surname> <given-names>J</given-names>
</name>
<name>
<surname>Homayouni-Rad</surname> <given-names>A</given-names>
</name>
<name>
<surname>Niafar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Asghari-Jafarabadi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mofid</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Probiotic yogurt improves antioxidant status in type 2 diabetic patients</article-title>. <source>Nutrition</source> (<year>2012</year>) <volume>28</volume>:<page-range>539&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.nut.2011.08.013</pub-id>
</citation>
</ref>
<ref id="B228">
<label>228</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martarelli</surname> <given-names>D</given-names>
</name>
<name>
<surname>Verdenelli</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Scuri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cocchioni</surname> <given-names>M</given-names>
</name>
<name>
<surname>Silvi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cecchini</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise training</article-title>. <source>Curr Microbiol</source> (<year>2011</year>) <volume>62</volume>:<page-range>1689&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00284-011-9915-3</pub-id>
</citation>
</ref>
<ref id="B229">
<label>229</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zilmer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Soomets</surname> <given-names>U</given-names>
</name>
<name>
<surname>Rehema</surname> <given-names>A</given-names>
</name>
<name>
<surname>Langel</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>The glutathione system as an attractive therapeutic target</article-title>. <source>Drug Design Reviews-Online (Discontinued)</source> (<year>2005</year>) <volume>2</volume>:<page-range>121&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.2174/1567269053202697</pub-id>
</citation>
</ref>
<ref id="B230">
<label>230</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xe4;ckhed</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ley</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Sonnenburg</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Gordon</surname> <given-names>JI</given-names>
</name>
</person-group>. <article-title>Host-bacterial mutualism in the human intestine</article-title>. <source>Science</source> (<year>2005</year>) <volume>307</volume>:<page-range>1915&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1104816</pub-id>
</citation>
</ref>
<ref id="B231">
<label>231</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berg</surname> <given-names>RD</given-names>
</name>
</person-group>. <article-title>The indigenous gastrointestinal microflora</article-title>. <source>Trends Microbiol</source> (<year>1996</year>) <volume>4</volume>:<page-range>430&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0966-842x(96)10057-3</pub-id>
</citation>
</ref>
<ref id="B232">
<label>232</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajili&#x107;-Stojanovi&#x107;</surname> <given-names>M</given-names>
</name>
<name>
<surname>Smidt</surname> <given-names>H</given-names>
</name>
<name>
<surname>de Vos</surname> <given-names>WM</given-names>
</name>
</person-group>. <article-title>Diversity of the human gastrointestinal tract microbiota revisited</article-title>. <source>Environ Microbiol</source> (<year>2007</year>) <volume>9</volume>:<page-range>2125&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-2920.2007.01369.x</pub-id>
</citation>
</ref>
<ref id="B233">
<label>233</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname> <given-names>WW</given-names>
</name>
<name>
<surname>Metz</surname> <given-names>C</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Roth</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The microbes of the intestine: an introduction to their metabolic and signaling capabilities</article-title>. <source>Endocrinol Metab Clin North Am</source> (<year>2008</year>) <volume>37</volume>:<page-range>857&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ecl.2008.08.006</pub-id>
</citation>
</ref>
<ref id="B234">
<label>234</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname> <given-names>DN</given-names>
</name>
<name>
<surname>St Amand</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Feldman</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Boedeker</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Harpaz</surname> <given-names>N</given-names>
</name>
<name>
<surname>Pace</surname> <given-names>NR</given-names>
</name>
</person-group>. <article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2007</year>) <volume>104</volume>:<page-range>13780&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0706625104</pub-id>
</citation>
</ref>
<ref id="B235">
<label>235</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function</article-title>. <source>Endocrine</source> (<year>2019</year>) <volume>64</volume>:<page-range>564&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12020-018-1831-x</pub-id>
</citation>
</ref>
<ref id="B236">
<label>236</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zitvogel</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ayyoub</surname> <given-names>M</given-names>
</name>
<name>
<surname>Routy</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kroemer</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Microbiome and anticancer immunosurveillance</article-title>. <source>Cell</source> (<year>2016</year>) <volume>165</volume>:<page-range>276&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2016.03.001</pub-id>
</citation>
</ref>
<ref id="B237">
<label>237</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajagopala</surname> <given-names>SV</given-names>
</name>
<name>
<surname>Vashee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Oldfield</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Venter</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Telenti</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>The human microbiome and cancer</article-title>. <source>Cancer Prev Res (Phila)</source> (<year>2017</year>) <volume>10</volume>:<page-range>226&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1940-6207.capr-16-0249</pub-id>
</citation>
</ref>
<ref id="B238">
<label>238</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benitez</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Hoffmann</surname> <given-names>C</given-names>
</name>
<name>
<surname>Muir</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Dods</surname> <given-names>KK</given-names>
</name>
<name>
<surname>Spergel</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Bushman</surname> <given-names>FD</given-names>
</name>
<etal/>
</person-group>. <article-title>Inflammation-associated microbiota in pediatric eosinophilic esophagitis</article-title>. <source>Microbiome</source> (<year>2015</year>) <volume>3</volume>:<fpage>23</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40168-015-0085-6</pub-id>
</citation>
</ref>
<ref id="B239">
<label>239</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dahmus</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Kotler</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Kastenberg</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Kistler</surname> <given-names>CA</given-names>
</name>
</person-group>. <article-title>The gut microbiome and colorectal cancer: a review of bacterial pathogenesis</article-title>. <source>J Gastrointest Oncol</source> (<year>2018</year>) <volume>9</volume>:<page-range>769&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/jgo.2018.04.07</pub-id>
</citation>
</ref>
<ref id="B240">
<label>240</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trapani</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Boghossian</surname> <given-names>LJ</given-names>
</name>
</person-group>. <article-title>Clostridium subterminale septicemia in a patient with metastatic gastrointestinal adenocarcinoma</article-title>. <source>Case Rep Infect Dis</source> (<year>2018</year>) <volume>2018</volume>:<fpage>6031510</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2018/6031510</pub-id>
</citation>
</ref>
<ref id="B241">
<label>241</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Virili</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fallahi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Antonelli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Benvenga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Centanni</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Gut microbiota and hashimoto&#x2019;s thyroiditis</article-title>. <source>Rev Endocr Metab Disord</source> (<year>2018</year>) <volume>19</volume>:<fpage>293</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11154-018-9467-y</pub-id>
</citation>
</ref>
<ref id="B242">
<label>242</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Rayman</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>H</given-names>
</name>
<name>
<surname>Schomburg</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>B</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Low population selenium status is associated with increased prevalence of thyroid disease</article-title>. <source>J Clin Endocrinol Metab</source> (<year>2015</year>) <volume>100</volume>:<page-range>4037&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2015-2222</pub-id>
</citation>
</ref>
<ref id="B243">
<label>243</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xfc;low Pedersen</surname> <given-names>I</given-names>
</name>
<name>
<surname>Knudsen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Carl&#xe9;</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schomburg</surname> <given-names>L</given-names>
</name>
<name>
<surname>K&#xf6;hrle</surname> <given-names>J</given-names>
</name>
<name>
<surname>J&#xf8;rgensen</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Serum selenium is low in newly diagnosed graves&#x2019; disease: a population-based study</article-title>. <source>Clin Endocrinol (Oxf)</source> (<year>2013</year>) <volume>79</volume>:<page-range>584&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cen.12185</pub-id>
</citation>
</ref>
<ref id="B244">
<label>244</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schomburg</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Selenium deficiency due to diet, pregnancy, severe illness, or COVID-19-A preventable trigger for autoimmune disease</article-title>. <source>Int J Mol Sci</source> (<year>2021</year>) <volume>22</volume>:<elocation-id>8532</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22168532</pub-id>
</citation>
</ref>
<ref id="B245">
<label>245</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krassas</surname> <given-names>GE</given-names>
</name>
<name>
<surname>Pontikides</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tziomalos</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tzotzas</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zosin</surname> <given-names>I</given-names>
</name>
<name>
<surname>Vlad</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Selenium status in patients with autoimmune and non-autoimmune thyroid diseases from four European countries</article-title>. <source>Expert Rev Endocrinol Metab</source> (<year>2014</year>) <volume>9</volume>:<page-range>685&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1586/17446651.2014.960845</pub-id>
</citation>
</ref>
<ref id="B246">
<label>246</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorini</surname> <given-names>F</given-names>
</name>
<name>
<surname>Sabatino</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Selenium: An element of life essential for thyroid function</article-title>. <source>Molecules</source> (<year>2021</year>) <volume>26</volume>:<elocation-id>7084</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26237084</pub-id>
</citation>
</ref>
</ref-list>
<glossary>
<title>Glossary</title>
<table-wrap position="anchor">
<table frame="hsides">
<tbody>
<tr>
<td valign="top" align="left">8-oxoG</td>
<td valign="top" align="left">8-oxo guanine</td>
</tr>
<tr>
<td valign="top" align="left">AMPK</td>
<td valign="top" align="left">adenosine monophosphate-activated protein kinase</td>
</tr>
<tr>
<td valign="top" align="left">BER</td>
<td valign="top" align="left">base excision repair</td>
</tr>
<tr>
<td valign="top" align="left">CAT</td>
<td valign="top" align="left">catalase</td>
</tr>
<tr>
<td valign="top" align="left">COX-2</td>
<td valign="top" align="left">cyclooxygenase-2</td>
</tr>
<tr>
<td valign="top" align="left">CRP</td>
<td valign="top" align="left">C-reactive protein</td>
</tr>
<tr>
<td valign="top" align="left">GD</td>
<td valign="top" align="left">Graves&#x2019; disease</td>
</tr>
<tr>
<td valign="top" align="left">GPR120</td>
<td valign="top" align="left">G-protein-coupled surface receptor 120</td>
</tr>
<tr>
<td valign="top" align="left">GPx</td>
<td valign="top" align="left">glutathione peroxidase</td>
</tr>
<tr>
<td valign="top" align="left">GR</td>
<td valign="top" align="left">glutathione reductase</td>
</tr>
<tr>
<td valign="top" align="left">GSH</td>
<td valign="top" align="left">glutathione</td>
</tr>
<tr>
<td valign="top" align="left">H2O2</td>
<td valign="top" align="left">hydrogen peroxide</td>
</tr>
<tr>
<td valign="top" align="left">iNOS</td>
<td valign="top" align="left">inducible nitric oxide synthase</td>
</tr>
<tr>
<td valign="top" align="left">IP</td>
<td valign="top" align="left">inositol phosphates</td>
</tr>
<tr>
<td valign="top" align="left">KEAP1</td>
<td valign="top" align="left">Kelch-like ECH-associated protein 1</td>
</tr>
<tr>
<td valign="top" align="left">LDL-C</td>
<td valign="top" align="left">low-density lipoprotein-cholesterol</td>
</tr>
<tr>
<td valign="top" align="left">LOX</td>
<td valign="top" align="left">lipoxygenase</td>
</tr>
<tr>
<td valign="top" align="left">MDA</td>
<td valign="top" align="left">malondialdehyde</td>
</tr>
<tr>
<td valign="top" align="left">MUFA</td>
<td valign="top" align="left">monounsaturated fatty acids</td>
</tr>
<tr>
<td valign="top" align="left">Myo</td>
<td valign="top" align="left">myoinositol</td>
</tr>
<tr>
<td valign="top" align="left">NFE2L2</td>
<td valign="top" align="left">nuclear factor erythroid 2-related factor 2 gene</td>
</tr>
<tr>
<td valign="top" align="left">NF-kB</td>
<td valign="top" align="left">nuclear factor-b</td>
</tr>
<tr>
<td valign="top" align="left">NIS</td>
<td valign="top" align="left">sodium/iodide symporter</td>
</tr>
<tr>
<td valign="top" align="left">NO</td>
<td valign="top" align="left">nitric oxide</td>
</tr>
<tr>
<td valign="top" align="left">NOXs</td>
<td valign="top" align="left">NADPH-oxidases</td>
</tr>
<tr>
<td valign="top" align="left">OSI</td>
<td valign="top" align="left">oxidative stress index</td>
</tr>
<tr>
<td valign="top" align="left">OxS</td>
<td valign="top" align="left">oxidative stress</td>
</tr>
<tr>
<td valign="top" align="left">p53</td>
<td valign="top" align="left">p53 tumour suppressor protein</td>
</tr>
<tr>
<td valign="top" align="left">PI</td>
<td valign="top" align="left">phosphatidylinositol</td>
</tr>
<tr>
<td valign="top" align="left">PIP</td>
<td valign="top" align="left">phosphoinositides</td>
</tr>
<tr>
<td valign="top" align="left">PPAR&#x3b3;</td>
<td valign="top" align="left">peroxisome proliferator-activated receptor &#x3b3;</td>
</tr>
<tr>
<td valign="top" align="left">PTC</td>
<td valign="top" align="left">papillary thyroid carcinoma</td>
</tr>
<tr>
<td valign="top" align="left">PUFA</td>
<td valign="top" align="left">polyunsaturated fatty acids</td>
</tr>
<tr>
<td valign="top" align="left">RNS</td>
<td valign="top" align="left">reactive nitrogen species</td>
</tr>
<tr>
<td valign="top" align="left">ROS</td>
<td valign="top" align="left">reactive oxygen species</td>
</tr>
<tr>
<td valign="top" align="left">SELENOS</td>
<td valign="top" align="left">selenoprotein S gene</td>
</tr>
<tr>
<td valign="top" align="left">SOD</td>
<td valign="top" align="left">superoxide dismutase</td>
</tr>
<tr>
<td valign="top" align="left">SOD1</td>
<td valign="top" align="left">cytoplasmic SOD</td>
</tr>
<tr>
<td valign="top" align="left">SOD2</td>
<td valign="top" align="left">mitochondrial SOD</td>
</tr>
<tr>
<td valign="top" align="left">SOD3</td>
<td valign="top" align="left">extracellular SOD</td>
</tr>
<tr>
<td valign="top" align="left">T2DM</td>
<td valign="top" align="left">type 2 diabetes mellitus</td>
</tr>
<tr>
<td valign="top" align="left">T3</td>
<td valign="top" align="left">triiodothyronine</td>
</tr>
<tr>
<td valign="top" align="left">T4</td>
<td valign="top" align="left">thyroxine</td>
</tr>
<tr>
<td valign="top" align="left">TAS</td>
<td valign="top" align="left">total antioxidant status</td>
</tr>
<tr>
<td valign="top" align="left">TG</td>
<td valign="top" align="left">thyroglobulin</td>
</tr>
<tr>
<td valign="top" align="left">TNF</td>
<td valign="top" align="left">tumour necrosis factor</td>
</tr>
<tr>
<td valign="top" align="left">TOS</td>
<td valign="top" align="left">total oxidative status</td>
</tr>
<tr>
<td valign="top" align="left">TPO</td>
<td valign="top" align="left">thyroid peroxidase</td>
</tr>
<tr>
<td valign="top" align="left">TRH</td>
<td valign="top" align="left">thyrotropin-releasing hormone</td>
</tr>
<tr>
<td valign="top" align="left">TSAb</td>
<td valign="top" align="left">thyroid-stimulating antibodies</td>
</tr>
<tr>
<td valign="top" align="left">TSH</td>
<td valign="top" align="left">thyroid-stimulating hormone</td>
</tr>
</tbody>
</table>
</table-wrap>
</glossary>
</back>
</article>